How to Increase Vitamen D-3 in a Chickens Diet

Implications of Vitamin D Research in Chickens can Advance Human Nutrition and Perspectives for the Future

Matthew F Warren,

Prestage Department of Poultry Science, North Carolina State University

, Raleigh, NC,

USA

Department of Nutritional Sciences, University of Wisconsin-Madison

, Madison, WI,

USA

Search for other works by this author on:

Kimberly A Livingston

Prestage Department of Poultry Science, North Carolina State University

, Raleigh, NC,

USA

Elanco Animal Health

, Greenfield, IN,

USA

Search for other works by this author on:

Received:

07 October 2020

Revision received:

09 February 2021

Accepted:

23 February 2021

Published:

25 February 2021

Abstract

The risk of vitamin D insufficiency in humans is a global problem that requires improving ways to increase vitamin D intake. Supplements are a primary means for increasing vitamin D intake, but without a clear consensus on what constitutes vitamin D sufficiency, there is toxicity risk with taking supplements. Chickens have been used in many vitamin-D-related research studies, especially studies involving vitamin D supplementation. Our state-of-the-art review evaluates vitamin D metabolism and how the different hydroxylated forms are synthesized. We provide an overview of how vitamin D is absorbed, transported, excreted, and what tissues in the body store vitamin D metabolites. We also discuss a number of studies involving vitamin D supplementation with broilers and laying hens. Vitamin D deficiency and toxicity are also described and how they can be caused. The vitamin D receptor (VDR) is important for vitamin D metabolism; however, there is much more to understand about VDR in chickens. Potential research aims involving vitamin D and chickens should explore VDR mechanisms that could lead to newer insights into VDR. Utilizing chickens in future research to help elucidate vitamin D mechanisms has great potential to advance human nutrition. Finding ways to increase vitamin D intake will be necessary because the coronavirus disease 2019 (COVID-19) pandemic is leading to increased risk of vitamin D deficiency in many populations. Chickens can provide a dual purpose with addressing pandemic-caused vitamin D deficiency: 1) vitamin D supplementation gives chickens added-value with the possibility of leading to vitamin-D-enriched meat and egg products; and 2) using chickens in research provides data for translational research. We believe expanding vitamin-D-related research in chickens to include more nutritional aims in vitamin D status has great implications for developing better strategies to improve human health.

Introduction

Globally, many humans are at risk of vitamin D insufficiency because they lack sufficient sunlight exposure or dietary intake of vitamin D (1, 2). Vitamin D is an essential nutrient due to its metabolic impact of increasing calcium (Ca) absorption in animals (3). Vitamin D is also a fascinating nutrient because its most active form acts as a hormone to exert its biological effect (4). Although vitamin D was traditionally associated with bone formation, the effects of vitamin D on the body are broad as it also affects various physiological systems, such as the immune or reproductive systems (5). Even though vitamin D research is one of the most funded in the USA (6), there are gaps in knowledge of understanding vitamin D in relation to excessive intake in humans that could be explored using animal models.

Domesticated poultry species like chicken (Gallus gallus) or turkey (Meleagris gallopavo) are becoming increasingly important as a food source for addressing world population demands (7). Chickens are a powerful research model because of their quick generation time, they can be housed in large numbers, and photoperiod affects their feeding behavior and hormonal regulation (8–10). Chickens are widely used for testing feed additive effects because of their quick response time that can be measured by growth performance (11–13). Chickens also have a preference to use cholecalciferol (vitamin D₃) over ergocalciferol (vitamin D₂) which has implications for examining pharmacological effects (14). Chickens provide a dimension of not only being important for research to understand metabolic mechanisms, but they are also a food source via meat and egg production. Laying hens are frequently used as an ovarian cancer model and have importance as a preclinical model for human ovarian cancer (10, 15, 16). Rodents and swine are mammalian models that have similar digestive tracts to humans, but there are factors in which chickens are superior for vitamin-D-related research, such as their preference for vitamin D₃ (14). Rats exhibit a preference for vitamin D₂ when fed both D₂ and D₃ as they were observed to circulate higher serum concentrations of 25-hydroxyergocalciferol (25-OH-D₂) compared to 25-hydroxycholecalciferol (25-OH-D₃) (17). Swine have a simple hindgut like humans, but it takes ∼6 mo to reach sexual maturity, a problem that is important when comparing nutritional impacts at adult stage (18).

The first half of this review focuses on an overview of vitamin D mechanisms with regards to vitamin D metabolism and its metabolites. The second half of this review surveys how vitamin D research in the chicken model can be a means of understanding vitamin D insufficiency in humans and managing it. Vitamin D toxicity is an area of research that has been experimentally observed in chickens. There needs to be a better understanding of how vitamin D supplementation concentrations are administered to avoid potential complications. We also discuss the significance of incorporating the vitamin D receptor (VDR) into future vitamin D research with chickens to focus on vitamin D mechanisms. The last section of this review is dedicated to describing how future research with vitamin D and chickens can help address high-impact areas of human nutrition. As a food source and research model, chickens provide a means to respond to vitamin D deficiency as a result of the coronavirus disease 2019 (COVID-19) pandemic. Our state-of-the-art review aims to highlight the research and added-value that chickens can bring to further understanding vitamin D.

Search strategy and methodology

We searched the literature, for studies published in the English language, using PubMed and Google Scholar. We searched from 1 January, 1960 to 4 February, 2021 to ensure we included some of the foundational studies involving vitamin D. Some of our references go back to 1928 and they were used because they were referenced in some of the published research articles that are referenced in our review. We included searches up to 4 February, 2021 to ensure any newly published clinical trials involving vitamin D in relation to COVID-19 were included in our review. The main search terms used were: vitamin D, chicken, broiler, laying hen, vitamin D metabolism, human vitamin D, plasma vitamin D, egg yolk vitamin, vitamin D and muscle, vitamin D and COVID-19. We did not set any exclusion criteria for studies when searching; however, we focused primarily on searching for studies involving chickens. We included studies that used different animal models (e.g. mouse, rat, pig, etc.) because it was important to include lab animal models as well as production animals with regards to this review's scope. We also included in vitro studies while searching because they could have an experimental approach of giving vitamin D to the animal before collecting their cells for in vitro experiments.

Vitamin D metabolites and mechanisms

There are 2 major classes of vitamin D which are further subdivided into various forms that exert hormonal and physiological effects or inactive forms that are excreted. Cholecalciferol (D₃) is a major class of vitamin D and is synthesized de novo by animals (19, 20) (Figure 1). Ergocalciferol (D₂) is another major class of vitamin D that is primarily synthesized by microalgae and fungi (21, 22). Animals can use both D₂ and D₃, but D₃ has been reported to have a higher binding affinity to VDR (23). Vitamin D has intact A, B, and D steroid rings due to photolysis of the B ring of 7-dehydrocholesterol (7-DHC or provitamin D₃) when compared with generic steroids (24). The structure of 7-DHC allows the A ring to have the conformational capacity to undergo interconversion between two chair configurations (25). The structure of D₃ comprises a saturated 8-carbon side chain, which is metabolically produced by photolysis of 7-DHC on the skin surface exposed to ultraviolet light irradiation (26). This review will focus on D₃ because of its bioavailability and involvement in humans and chickens.

FIGURE 1

Comparison of vitamin D precursors and their nutritionally relevant forms vitamin D3 and D2. In animals, when ultraviolet B rays (UVB) or sunlight hits 7-dehydrocholesterol (7-DHC) on the skin, then 7-DHC will undergo multiple reactions and be converted to cholecalciferol (vitamin D3). In fungi and microalgae, ergosterol undergoes the same pathway as 7-DHC to become ergocalciferol (vitamin D2).

Comparison of vitamin D precursors and their nutritionally relevant forms vitamin D₃ and D₂. In animals, when ultraviolet B rays (UVB) or sunlight hits 7-dehydrocholesterol (7-DHC) on the skin, then 7-DHC will undergo multiple reactions and be converted to cholecalciferol (vitamin D₃). In fungi and microalgae, ergosterol undergoes the same pathway as 7-DHC to become ergocalciferol (vitamin D₂).

FIGURE 1

Vitamin D₃ synthesis in animals is a quick process dependent on exposure of the skin to ultraviolet B rays (UVB, 290–315 nm) (1). Vitamin D₃ synthesis begins when cholesterol is converted to 7-DHC in the skin (Figure 2). UVB interacts with 7-DHC by opening the electrolytic ring between carbons 9 and 10 of the B ring as a result of light absorption, converting 7-DHC to previtamin D₃ (25, 27). Previtamin D₃ can photochemically convert to lumisterol, tachysterol, or D₃ via thermal isomerization. D₃ is a major product of thermal isomerization as it requires the least energy for thermal rearrangement. D₃ on skin that is exposed too long to sunlight will be degraded to 5,6-trans-vitamin D₃ which has no calcemic effects like lumisterol or tachysterol (28). Thermal rearrangement gives previtamin D₃ and D₃ a state of equilibrium and reversibility; although this equilibrium favors D_3. De novo synthesis in humans converts 10–15% of available 7-DHC to D₃ (26). The physical "sun-screen" properties of the skin, such as melanin resulting in darker skin, reduces yield; environmental factors such as time of day, season, and latitude also affect yield (20, 29). The biological half-life of D₃ was suggested to be 50 h in human plasma, but radioisotopically labeled D₃ was observed to last 4 d (30, 31). Vitamin D₃ can subsequently convert into different metabolite forms as illustrated inFigure 3.

FIGURE 2

Biochemical reactions of 7-dehydrocholesterol (7-DHC) that leads to synthesis of vitamin D₃ and potential noncalcemic metabolites. When ultraviolet B rays (UVB) or sunlight hits 7-dehydrocholesterol (7-DHC) on the skin, 7-DHC is converted to previtamin D₃ which is then converted to vitamin D₃, lumisterol-3, or tachysterol-3 by thermal isomerization. Vitamin D₃ enters the blood circulation to be hydroxylated to its more active forms. Vitamin D₃ in the skin can be converted to 5,6-trans-vitamin D₃ by UVB if it does not go into the circulation. Adapted with permission from (27) and (32).

FIGURE 2

FIGURE 3

Metabolic pathway of vitamin D₃ to its subsequent metabolite forms. Vitamin D₃ in circulation goes to the liver to be converted to 25-hydroxycholecalciferol (25-OH-D₃). 25-OH-D₃ can be further hydroxylated to either 24,25-dihydroxycholecalciferol [24,25-(OH)₂-D₃] or 1,25-dihydroxycholecalciferol [1,25-(OH)₂-D₃]. When 1,25-(OH)₂-D₃ binds to the vitamin D receptor, then biological effects are exerted through gene transcription. 1,25-(OH)₂-D₃ can also be further hydroxylated by 24-hydroxylase to 1,24,25-trihydroxycholecalciferol and undergoes a series of reactions to ultimately become calcitroic acid, a water-soluble metabolite that is safely excreted in urine. Adapted with permission from (27) and (32).

FIGURE 3

Feathers cover the skin on birds and also reflect UVB (33), which likely prevents 7-DHC on the skin from being converted to previtamin D₃. The earliest research on biogenic vitamin D in chickens was in the 1920s when Hou (34) described how surgically removing the preen (or uropygial) gland can cause rickets in chicks that were exposed to UVB or sunlight. The preen gland produces preen oil, which is a lipid compound that birds rub onto feathers to waterproof them (35, 36). It was proposed back then that preen oil contained vitamin D precursors and birds rubbing the oil onto feathers is what led to vitamin D synthesis (34, 37). In 1953, Knowles et al. (37) published findings that 10-d-old chicks were able to grow properly even after their preen glands were removed, suggesting that the preen gland was not needed for calcium metabolism. Rosenberg (38) published findings on how the preen glands in ducks, geese, and chickens had no 7-DHC and concluded that preening feathers was not how birds acquired vitamin D₃. A previous study described how laying hens fed a vitamin-D₃-deficient diet and exposed to UVB were able to lay eggs fortified with vitamin D₃ (39). Therefore, chickens would not be limited in vitamin D research with approaches involving UVB.

25-Hydroxylation

Most vitamin D is taken up by the liver and is hydroxylated at side chain C-25 to yield 25-OH-D₃. 25-OH-D₃ is the major circulating form of vitamin D₃, and it is synthesized in the liver of mammals (40–42) and the intestine, liver, and kidneys of birds (43, 44). Hydroxylation of C-25 is facilitated by the enzyme 25-hydroxylase (25-OHase), which consists of ≥6 cytochrome P-450-dependent mixed-function oxygenases of varying binding affinities and capacities (45). The vitamin D binding protein (DBP) binds to circulating 25-OH-D₃ in the blood, which is why 25-OH-D₃ is the major circulating form of vitamin D₃(46). Circulating concentrations of 25-OH-D₃ along with DBP are valuable for vitamin D status to determine vitamin D deficiency or toxicity (46, 47). There is no consensus on what circulating concentration of 25-OH-D₃ is normal in humans, but it appears to be ∼32–100 ng/mL with intoxication beginning above 150 ng/mL (1, 48). The 25-OH-D₃ concentration in an adult chicken is ∼25.3 ng/mL, whereas in an adult turkey it is lower at 18.2 ng/mL (49). Although 25-OHase and 25-hydroxylation is predominant in the liver, there have been studies that observed 25-OHase expression in the small intestine (44, 50). The half-life of 25-OH-D₃ in humans is ≥18 d and is much greater than D₃ (50 h) (51, 52). 25-OH-D₃ is used as a vitamin D₃ status indicator in humans, and clinical trials normally administer D₃ or 25-OH-D₃ as intravenous, intramuscular, or oral doses to examine how vitamin D₃ status is affected (53–58).

1-Hydroxylation

25-OH-D₃ undergoes an additional hydroxylation step at the 1-C position by 1α-hydroxylase (1α-OHase) to yield 1,25-dihydroxycholecalciferol [1,25-(OH)₂-D₃] in the kidney of mammals and chickens (59, 60). This is also why vitamin D is considered a hormone because 25-OH-D₃ has to be transported via circulation to the kidney for further hydroxylation (4, 61). Although most 1-hydroxylation occurs in the kidney, there are extrarenal tissues such as lymph nodes that express 1α-OHase to convert 25-OH-D₃ to 1,25-(OH)₂-D₃, denoting its possible function as a modulator for vitamin D activities in those tissues (62, 63). Given the strict regulation (64) and the fast turnover rate (65–67), 1,25-(OH)₂-D₃ is a poor biomarker for vitamin D status (68).

Considering 1,25-(OH)₂-D₃ is the vitamin D form that exerts biological effects as a ligand for VDR, 1α-OHase activity is tightly regulated to avoid homeostatic imbalance (69). 1α-OHase is primarily regulated by the parathyroid hormone (PTH), fibroblast growth factor 23, Ca, phosphate, and 1,25-(OH)₂-D₃ (70–73). Administering PTH stimulates the renal production of 1,25-(OH)₂-D₃ (74, 75), though this PTH effect can be mirrored using cAMP, which indicates that a part of the effect of PTH on 1,25-(OH)₂-D₃ production is mediated by adenylate cyclase (70). However, it is not clear how PTH mediates 1α-OHase gene expression (76).

24-Hydroxylation

Hydroxylation of C-24 can occur with 25-OH-D₃ or 1,25-(OH)₂-D₃, which results in 24,25-dihydroxycholecalciferol [24,25-(OH)₂-D₃] and 1,24,25-trihydroxycholecalciferol, respectively (77, 78). 24,25-(OH)₂-D₃ is considered an inactive form of vitamin D because studies have shown that 24,25-(OH)₂-D₃ inhibits signaling cascades involved with Ca and phosphorus (P) absorption which also inhibits bone mineralization (79). The 24-hydroxylase (24-OHase) enzyme is responsible for 24-hydroxylation (80). Studies with rats reported that 24-OHase activity occurs in the kidney and intestine (74, 81). It was also noted that the intestinal 24-OHase K _m value for 1,25-(OH)₂-D₃ is similar to kidney 24-OHase, leading to speculation that the intestinal role of 24-OHase was to initiate degradation of 1,25-(OH)₂-D₃ (74). In chickens, 24-OHase expression was highest in the kidney, then thymus and bursa, then intestine, lower in various muscle tissues, and little to no expression in the liver and was not statistically relevant (59).

An in vitro study reported how rat kidney 24-OHase expression increased in the absence of PTH (60). Infants diagnosed with idiopathic infantile hypercalcemia had severe hypercalcemia and a genetic mutation of 24-OHase (82). Hypercalcemia is caused by unregulated Ca absorption as an effect of increased sensitivity to vitamin D without 24-OHase. Reduced 24,25-(OH)₂-D serum concentration can also be indicative of chronic kidney disease due to the negative correlation of 24,25-(OH)₂-D with increasing PTH concentrations (83). 24-OHase-null mice without 24-OHase activity are unable to convert 1,25-(OH)₂-D₃ to its 24-hydroxylated forms (79). The mice had 49% mortality rate at weaning and impaired bone mineralization (84). Even though 24-OHase is tightly regulated by 1,25-(OH)₂-D₃, it is important to maintain Ca homeostasis by preventing hypercalcemia (85). The half-life of serum 24,25-(OH)₂-D₃ may not be as long as 25-OH-D₃ but it can last ≥15 d (86, 87).

1-α-Hydroxycholecalciferol

First synthesized and described in 1973 (88), 1-α-hydroxycholecalciferol (1α-OH-D₃) is a synthetic form of vitamin D₃ that has a similar efficacy to 1,25-(OH)₂-D₃, but has an added benefit of being cheaper to synthesize for dietary uses (89). It is assumed that the 1-α-hydroxyl group on 1α-OH-D₃ is structurally required for the hormonal activity of vitamin D (89). 1α-OH-D₃ is readily used in humans with renal cancer due to vitamin D deficiency caused by the lack of 1α-OHase activity to synthesize 1,25-(OH)₂-D₃ in the kidneys (90, 91). However, 1α-OHase is a critical regulatory enzyme that prevents the overproduction of 1,25-(OH)₂-D₃ because 24-OHase works to regulate serum 1,25-(OH)₂-D₃ concentrations (92, 93). Therefore, it is possible that 1α-OH-D₃ can result in hypercalcemia. The mode of action of 1α-OH-D₃ indicates it is able to avoid the critical regulation necessary to maintain homeostatic concentrations of 1,25-(OH)₂-D₃ and bypass the negative feedback mechanism caused by 1α-OHase activity (89). It is not clear what the half-life of 1α-OH-D₃ is in serum, but its biological activity from intravenous administration can last ∼12–16 h (89, 94).

Vitamin D absorption, transportation, excretion, and tissue distribution

Vitamin D absorption occurs in the small intestine by passive diffusion via micelle solubilization and cholesterol transporters (95–97). As a fat-soluble vitamin, vitamin D is dependent on fats and bile salts to be absorbed; otherwise, its absorption is greatly decreased, similar to how lipids are metabolized (98). Rats given pharmacological doses of D₃ absorbed a greater amount in the proximal part of the small intestine than the distal part without any signs of saturation (99). However, the dietary vitamin D absorption efficacy differs between animals, whereby young chicks and turkey poults absorb ∼84% intestinal D₃ (100), whereas humans absorb almost 20% (101), and rats absorb 42% (102). The high level of absorption in chicks and poults also highlights why they are good models for vitamin D research. Poultry are highly susceptible to vitamin D deficiency due to malabsorption caused by infectious or noninfectious factors. Vitamin D also lacks an active transport mechanism unlike vitamin K₁ (103) or A (104), which suggests that absorption could lead to toxic concentrations if there is excessive intake (99). Chickens are able to absorb dietary vitamin D₂; however, their capacity to absorb vitamin D₂ is low as chicks had to be given a daily dose of 1000 IU D₂ to have the same body weight as chicks given 100 IU D₃/d (14). The reason for the reduced absorptive efficacy of D₂ in chickens is a result of a faster clearance rate because D₂ is outcompeted in the process of binding to DBP compared to D₃ (105). Once absorbed, dietary vitamin D will go into lymphatic circulation in chylomicra. Polar metabolite forms of vitamin D₃ (25-OH-D₃; 1,25-(OH)₂-D₃) are transported by DBP (46).

Translocation of de novo synthesized vitamin D₃ from the skin is facilitated by DBP (106). Almost all circulating vitamin D₃ is bound to protein (107). In rats, DBP contains 458 amino acid residues and has a molecular weight of 54–58 kDa (108). Chickens have 2 DBPs, 54 and 60 kDa, both of which preferentially bind to 25-OH-D₃ over 25-OH-D₂, which also explains why D₂ has a lower bioavailability in chickens (109). In well-nourished humans, DBP binds ∼88% of the 25-OH-D₃ in serum with a much greater affinity than 1,25-(OH)₂-D₃, signifying the binding affinity of DBP is dependent on stochiometric aspects of vitamin D which differs based on the hydroxyl grouping (110). DBP is also maintained at a significant concentration in plasma that greatly exceeds the concentration of 25-OH-D₃ (111). Serum DBP is lower in Black Americans compared with white Americans, which suggests that the lower concentrations of serum 25-OH-D₃ in Black Americans is connected to their DBP concentration (112) (Table 1). Also, a study exploring 25-OH-D₃ in trans individuals receiving exogenous hormonal treatment reported no differences in serum 25-OH-D and transwomen trending towards an increase in DBP (113) (Table 1). Plasma DBP has a short turnover time (111) (1–3 d) compared to plasma 25-OH-D₃ which is ≥18 d (52). There are alleles of DBP polymorphisms that are inversely related to circulating 25-OH-D₃ which is dependent on vitamin D intake (114).

When the 25-OH-D₃ blood concentration needs to be decreased, the body can convert 25-OH-D₃ to 24,25-(OH)₂-D₃ (78). 24-Hydroxylation generates biologically inactive forms of vitamin D that are bound to bile and excreted in feces (115). Ultimately, this pathway results in a water-soluble molecule called calcitroic acid that will be safely excreted (115) (Figure 3). Esvelt and DeLuca (116) observed calcitroic acid had a much lower binding affinity to VDR from chick intestines with a similar binding affinity to 24,25-(OH)₂-D₃ compared with 1,25-(OH)₂-D₃, which indicated calcitroic acid and 24,25-(OH)₂-D₃ were inactive vitamin D₃ forms.

Vitamin D₃ is found and stored in multiple tissues, such as adipose tissue, skeletal muscle tissue, bone, liver, intestinal mucosa, (117, 118), brain (119), and skin (26). Adipose tissue contains the highest concentrations of vitamin D₃ with skeletal muscles being the second highest storage site for vitamin D₃ (117). Vitamin D₃ is found in the mammalian liver, but the liver contains high concentrations of 25-OH-D₃ as the liver is a transient organ for hydroxylating vitamin D₃ to 25-OH-D₃ (120, 121). Plasma vitamin D is mostly 25-OH-D₃ and then 24,25-(OH)₂-D₃ (49). Variable concentrations of distributed vitamin D₃ and its multiple metabolite forms denote differences in tissue lipid content and DBP associated with tissues.

Addressing vitamin D insufficiency in humans by understanding vitamin D metabolism in chickens

It has recently been speculated that vitamin D deficiency in humans will be a global issue for addressing health due to implications related to osteomalacia (122–124). Clinical studies are important for applying research findings to advance human health. Although there are many more clinical studies in the literature as reviewed by Plum and DeLuca (125), we highlight 2 clinical study examples that examined vitamin D supplementation in humans. One study noted how vitamin D₃ supplementation given during pregnancy could reduce adverse outcomes related to excessive inflammation (126) (Table 1). Another study observed how vitamin D₃ supplementation improved vitamin D status in overweight and obese African Americans (127) (Table 1). One drawback with clinical trials is controlling the variation of vitamin D intake, whether it is caused by sunlight exposure between participants or their diet, outside of the experimental study, can affect vitamin D status (128). A secondary drawback is when participants fail to adhere to their daily supplementation as part of the study design (129). Clinical trials are powerful for ascertaining treatment effects in humans and complement animal studies that can validate effects in controlled environments.

TABLE 1

Summary of selected studies involving humans, vitamin D supplementation, and their outcomes

Sex	Objective	Treatment regimen	Research findings	Refs
Vitamin D supplementation and disease
♂ + ♀	Determined the efficacy of 1α-OH-D₃ as a replacement for 1,25-(OH)₂-D₃ in 3 patients with chronic renal failure	• 3 patients were given 1α-OH-D₃ and 1,25-(OH)₂-D₃ intravenously• Intestinal absorption of radioactive calcium was measured	1α-OH-D₃ was effective in improving calcium absorption in the patients; 1α-OH-D₃ required a higher dose to have a similar effect to 1,25-(OH)₂-D₃	(90)
♂ + ♀	Compared D₃ and 25-OH-D₃ absorption in the intestine in 9 patients with chronic liver disease	• Patients were given a dose of 250 mL radiolabeled D₃ or 25-OH-D₃ of liquid formula diet• Serum samples were collected at 0, 4, 8, 12, and 24 h after the dose	Control subjects had peak absorption of ∼21% for D₃ at 12 h and over 40% for 25-OH-D₃ at 8 h; subjects with severe cholestatic liver disease had peak absorption of ∼1% for D₃ at 4 h and ∼12% for 25-OH-D₃ at 4 h	(101)
♂ + ♀	Assessed if vitamin D supplementation given to overweight or obese African Americans improved their vitamin D status and insulin sensitivity	• Participants were given 4000 IU D₃/d (100 µg/d) or placebo and supplemental calcium of 600 mg/d for 12 wk• Participants had their measurements collected on days 0, 42, and 84 and underwent a 2-h glucose tolerance test	Vitamin D supplementation did not show evidence of reducing diabetes risk; vitamin D supplementation increased serum 25-OH-D₃ over time	(127)
♂ + ♀	Evaluated vitamin D and calcium supplementation programs involving elderly men and women in northern European regions	• Community-dwelling residents of age 66 y old or older were given 2 daily supplements • Calcium supplement was 1000 mg elemental calcium as calcium carbonate• Vitamin D₃ supplement was 400 µg	Active participants in the programs had a reduction in bone fracture incidence; vitamin D and calcium supplementation could reduce osteoporotic fractures in elderly people in vitamin-D-deficient regions	(130)
Vitamin D supplementation effects on biomarkers
♂	Explored if circulating DBP and DBP genotypes were different between Black Americans and white Americans	• Patients between the ages of 30 and 64 y old were recruited • Dietary calcium and vitamin D, serum 25-OH-D₂ and 25-OH-D₃, and patients' genotypes for DBP single-nucleotide polymorphisms were measured	Black Americans had lower concentrations of total 25-OH-D₂ and 25-OH-D₃ and DBP compared to white Americans; there is some genetic variation in DBP between Black Americans and white Americans	(112)
♀	Assessed vitamin D supplementation effects during pregnancy on vitamin D status and immune markers associated with adverse pregnancy outcomes	• Pregnant women <20 wk to delivery were given 2 doses of D₃ as supplement capsules• Treatment doses: 10 µg/d or 50 µg/d D₃ (400 or 2000 IU D₃/d)	Higher vitamin D₃ supplementation caused an increase in serum 25-OH-D₃ concentration; increased the peripheral blood IL-10 regulatory CD4⁺ T cell percentage; vitamin D supplement impacts on increasing regulatory T cell concentrations could reduce inflammation associated with pregnancy	(126)
Vitamin D measurements
♂ + ♀	Examined exogenous HT effects on 25-OH-D and DBP in trans individuals	• Transwomen and transmen received exogenous HT for 3 mo• Baseline and 3 mo serum samples were collected and total 25-OH-D, free 25-OH-D, albumin, and DBP were measured	HT did not affect total 25-OH-D concentration in transwomen and transmen; transwomen trended towards an increase in DBP; trans individuals receiving HT does not affect vitamin D status assessments	(113) ¹
♂	Quantified the relation with D₃ input and serum 25-OH-D₃ concentration during winter months in men	• Men from Omaha, NE, were randomly assigned a treatment group and given a daily supplement in tablet form• Treatments were: placebo, supplemental D₃ (25 µg), and 1 or 2 tablets containing 125 µg D₃	Serum 25-OH-D₃ was increased by D₃ dose amount; data suggests that average daily vitamin D intake should be ∼5000 IU/d or 125 µg/d to maintain serum 25-OH-D₃ during winter months	(54)
Vitamin D receptor
♂	Determined VDR and 1α-OHase were expressed in human brain tissue	• Human brain tissue from 5 men, free of any psychopathology or substance abuse• Tissues were sectioned and stained with primary antibody for VDR and secondary antibodies for VDR or 1α-OHase	VDR is widespread throughout brain tissue except in layers in the cerebellum; 1α-OHase is expressed in the same regions as VDR, including the cerebellar layers that VDR was not expressed in	(131)

Sex	Objective	Treatment regimen	Research findings	Refs
Vitamin D supplementation and disease
♂ + ♀	Determined the efficacy of 1α-OH-D₃ as a replacement for 1,25-(OH)₂-D₃ in 3 patients with chronic renal failure	• 3 patients were given 1α-OH-D₃ and 1,25-(OH)₂-D₃ intravenously• Intestinal absorption of radioactive calcium was measured	1α-OH-D₃ was effective in improving calcium absorption in the patients; 1α-OH-D₃ required a higher dose to have a similar effect to 1,25-(OH)₂-D₃	(90)
♂ + ♀	Compared D₃ and 25-OH-D₃ absorption in the intestine in 9 patients with chronic liver disease	• Patients were given a dose of 250 mL radiolabeled D₃ or 25-OH-D₃ of liquid formula diet• Serum samples were collected at 0, 4, 8, 12, and 24 h after the dose	Control subjects had peak absorption of ∼21% for D₃ at 12 h and over 40% for 25-OH-D₃ at 8 h; subjects with severe cholestatic liver disease had peak absorption of ∼1% for D₃ at 4 h and ∼12% for 25-OH-D₃ at 4 h	(101)
♂ + ♀	Assessed if vitamin D supplementation given to overweight or obese African Americans improved their vitamin D status and insulin sensitivity	• Participants were given 4000 IU D₃/d (100 µg/d) or placebo and supplemental calcium of 600 mg/d for 12 wk• Participants had their measurements collected on days 0, 42, and 84 and underwent a 2-h glucose tolerance test	Vitamin D supplementation did not show evidence of reducing diabetes risk; vitamin D supplementation increased serum 25-OH-D₃ over time	(127)
♂ + ♀	Evaluated vitamin D and calcium supplementation programs involving elderly men and women in northern European regions	• Community-dwelling residents of age 66 y old or older were given 2 daily supplements • Calcium supplement was 1000 mg elemental calcium as calcium carbonate• Vitamin D₃ supplement was 400 µg	Active participants in the programs had a reduction in bone fracture incidence; vitamin D and calcium supplementation could reduce osteoporotic fractures in elderly people in vitamin-D-deficient regions	(130)
Vitamin D supplementation effects on biomarkers
♂	Explored if circulating DBP and DBP genotypes were different between Black Americans and white Americans	• Patients between the ages of 30 and 64 y old were recruited • Dietary calcium and vitamin D, serum 25-OH-D₂ and 25-OH-D₃, and patients' genotypes for DBP single-nucleotide polymorphisms were measured	Black Americans had lower concentrations of total 25-OH-D₂ and 25-OH-D₃ and DBP compared to white Americans; there is some genetic variation in DBP between Black Americans and white Americans	(112)
♀	Assessed vitamin D supplementation effects during pregnancy on vitamin D status and immune markers associated with adverse pregnancy outcomes	• Pregnant women <20 wk to delivery were given 2 doses of D₃ as supplement capsules• Treatment doses: 10 µg/d or 50 µg/d D₃ (400 or 2000 IU D₃/d)	Higher vitamin D₃ supplementation caused an increase in serum 25-OH-D₃ concentration; increased the peripheral blood IL-10 regulatory CD4⁺ T cell percentage; vitamin D supplement impacts on increasing regulatory T cell concentrations could reduce inflammation associated with pregnancy	(126)
Vitamin D measurements
♂ + ♀	Examined exogenous HT effects on 25-OH-D and DBP in trans individuals	• Transwomen and transmen received exogenous HT for 3 mo• Baseline and 3 mo serum samples were collected and total 25-OH-D, free 25-OH-D, albumin, and DBP were measured	HT did not affect total 25-OH-D concentration in transwomen and transmen; transwomen trended towards an increase in DBP; trans individuals receiving HT does not affect vitamin D status assessments	(113) ¹
♂	Quantified the relation with D₃ input and serum 25-OH-D₃ concentration during winter months in men	• Men from Omaha, NE, were randomly assigned a treatment group and given a daily supplement in tablet form• Treatments were: placebo, supplemental D₃ (25 µg), and 1 or 2 tablets containing 125 µg D₃	Serum 25-OH-D₃ was increased by D₃ dose amount; data suggests that average daily vitamin D intake should be ∼5000 IU/d or 125 µg/d to maintain serum 25-OH-D₃ during winter months	(54)
Vitamin D receptor
♂	Determined VDR and 1α-OHase were expressed in human brain tissue	• Human brain tissue from 5 men, free of any psychopathology or substance abuse• Tissues were sectioned and stained with primary antibody for VDR and secondary antibodies for VDR or 1α-OHase	VDR is widespread throughout brain tissue except in layers in the cerebellum; 1α-OHase is expressed in the same regions as VDR, including the cerebellar layers that VDR was not expressed in	(131)

Trans individuals in this study are on exogenous hormonal treatment.

♂, male; ♀, female; 1α-OH-D₃, 1-α-hydroxycholecalciferol; 1α-OHase, 1α-hydroxylase; 1,25-(OH)₂-D₃, 1,25-dihydroxycholecalciferol; 25-OH-D₃, 25-hydroxycholecalciferol; DBP, vitamin D binding protein; HT, hormonal treatment; VDR, vitamin D receptor.

TABLE 1

Summary of selected studies involving humans, vitamin D supplementation, and their outcomes

Sex	Objective	Treatment regimen	Research findings	Refs
Vitamin D supplementation and disease
♂ + ♀	Determined the efficacy of 1α-OH-D₃ as a replacement for 1,25-(OH)₂-D₃ in 3 patients with chronic renal failure	• 3 patients were given 1α-OH-D₃ and 1,25-(OH)₂-D₃ intravenously• Intestinal absorption of radioactive calcium was measured	1α-OH-D₃ was effective in improving calcium absorption in the patients; 1α-OH-D₃ required a higher dose to have a similar effect to 1,25-(OH)₂-D₃	(90)
♂ + ♀	Compared D₃ and 25-OH-D₃ absorption in the intestine in 9 patients with chronic liver disease	• Patients were given a dose of 250 mL radiolabeled D₃ or 25-OH-D₃ of liquid formula diet• Serum samples were collected at 0, 4, 8, 12, and 24 h after the dose	Control subjects had peak absorption of ∼21% for D₃ at 12 h and over 40% for 25-OH-D₃ at 8 h; subjects with severe cholestatic liver disease had peak absorption of ∼1% for D₃ at 4 h and ∼12% for 25-OH-D₃ at 4 h	(101)
♂ + ♀	Assessed if vitamin D supplementation given to overweight or obese African Americans improved their vitamin D status and insulin sensitivity	• Participants were given 4000 IU D₃/d (100 µg/d) or placebo and supplemental calcium of 600 mg/d for 12 wk• Participants had their measurements collected on days 0, 42, and 84 and underwent a 2-h glucose tolerance test	Vitamin D supplementation did not show evidence of reducing diabetes risk; vitamin D supplementation increased serum 25-OH-D₃ over time	(127)
♂ + ♀	Evaluated vitamin D and calcium supplementation programs involving elderly men and women in northern European regions	• Community-dwelling residents of age 66 y old or older were given 2 daily supplements • Calcium supplement was 1000 mg elemental calcium as calcium carbonate• Vitamin D₃ supplement was 400 µg	Active participants in the programs had a reduction in bone fracture incidence; vitamin D and calcium supplementation could reduce osteoporotic fractures in elderly people in vitamin-D-deficient regions	(130)
Vitamin D supplementation effects on biomarkers
♂	Explored if circulating DBP and DBP genotypes were different between Black Americans and white Americans	• Patients between the ages of 30 and 64 y old were recruited • Dietary calcium and vitamin D, serum 25-OH-D₂ and 25-OH-D₃, and patients' genotypes for DBP single-nucleotide polymorphisms were measured	Black Americans had lower concentrations of total 25-OH-D₂ and 25-OH-D₃ and DBP compared to white Americans; there is some genetic variation in DBP between Black Americans and white Americans	(112)
♀	Assessed vitamin D supplementation effects during pregnancy on vitamin D status and immune markers associated with adverse pregnancy outcomes	• Pregnant women <20 wk to delivery were given 2 doses of D₃ as supplement capsules• Treatment doses: 10 µg/d or 50 µg/d D₃ (400 or 2000 IU D₃/d)	Higher vitamin D₃ supplementation caused an increase in serum 25-OH-D₃ concentration; increased the peripheral blood IL-10 regulatory CD4⁺ T cell percentage; vitamin D supplement impacts on increasing regulatory T cell concentrations could reduce inflammation associated with pregnancy	(126)
Vitamin D measurements
♂ + ♀	Examined exogenous HT effects on 25-OH-D and DBP in trans individuals	• Transwomen and transmen received exogenous HT for 3 mo• Baseline and 3 mo serum samples were collected and total 25-OH-D, free 25-OH-D, albumin, and DBP were measured	HT did not affect total 25-OH-D concentration in transwomen and transmen; transwomen trended towards an increase in DBP; trans individuals receiving HT does not affect vitamin D status assessments	(113) ¹
♂	Quantified the relation with D₃ input and serum 25-OH-D₃ concentration during winter months in men	• Men from Omaha, NE, were randomly assigned a treatment group and given a daily supplement in tablet form• Treatments were: placebo, supplemental D₃ (25 µg), and 1 or 2 tablets containing 125 µg D₃	Serum 25-OH-D₃ was increased by D₃ dose amount; data suggests that average daily vitamin D intake should be ∼5000 IU/d or 125 µg/d to maintain serum 25-OH-D₃ during winter months	(54)
Vitamin D receptor
♂	Determined VDR and 1α-OHase were expressed in human brain tissue	• Human brain tissue from 5 men, free of any psychopathology or substance abuse• Tissues were sectioned and stained with primary antibody for VDR and secondary antibodies for VDR or 1α-OHase	VDR is widespread throughout brain tissue except in layers in the cerebellum; 1α-OHase is expressed in the same regions as VDR, including the cerebellar layers that VDR was not expressed in	(131)

Sex	Objective	Treatment regimen	Research findings	Refs
Vitamin D supplementation and disease
♂ + ♀	Determined the efficacy of 1α-OH-D₃ as a replacement for 1,25-(OH)₂-D₃ in 3 patients with chronic renal failure	• 3 patients were given 1α-OH-D₃ and 1,25-(OH)₂-D₃ intravenously• Intestinal absorption of radioactive calcium was measured	1α-OH-D₃ was effective in improving calcium absorption in the patients; 1α-OH-D₃ required a higher dose to have a similar effect to 1,25-(OH)₂-D₃	(90)
♂ + ♀	Compared D₃ and 25-OH-D₃ absorption in the intestine in 9 patients with chronic liver disease	• Patients were given a dose of 250 mL radiolabeled D₃ or 25-OH-D₃ of liquid formula diet• Serum samples were collected at 0, 4, 8, 12, and 24 h after the dose	Control subjects had peak absorption of ∼21% for D₃ at 12 h and over 40% for 25-OH-D₃ at 8 h; subjects with severe cholestatic liver disease had peak absorption of ∼1% for D₃ at 4 h and ∼12% for 25-OH-D₃ at 4 h	(101)
♂ + ♀	Assessed if vitamin D supplementation given to overweight or obese African Americans improved their vitamin D status and insulin sensitivity	• Participants were given 4000 IU D₃/d (100 µg/d) or placebo and supplemental calcium of 600 mg/d for 12 wk• Participants had their measurements collected on days 0, 42, and 84 and underwent a 2-h glucose tolerance test	Vitamin D supplementation did not show evidence of reducing diabetes risk; vitamin D supplementation increased serum 25-OH-D₃ over time	(127)
♂ + ♀	Evaluated vitamin D and calcium supplementation programs involving elderly men and women in northern European regions	• Community-dwelling residents of age 66 y old or older were given 2 daily supplements • Calcium supplement was 1000 mg elemental calcium as calcium carbonate• Vitamin D₃ supplement was 400 µg	Active participants in the programs had a reduction in bone fracture incidence; vitamin D and calcium supplementation could reduce osteoporotic fractures in elderly people in vitamin-D-deficient regions	(130)
Vitamin D supplementation effects on biomarkers
♂	Explored if circulating DBP and DBP genotypes were different between Black Americans and white Americans	• Patients between the ages of 30 and 64 y old were recruited • Dietary calcium and vitamin D, serum 25-OH-D₂ and 25-OH-D₃, and patients' genotypes for DBP single-nucleotide polymorphisms were measured	Black Americans had lower concentrations of total 25-OH-D₂ and 25-OH-D₃ and DBP compared to white Americans; there is some genetic variation in DBP between Black Americans and white Americans	(112)
♀	Assessed vitamin D supplementation effects during pregnancy on vitamin D status and immune markers associated with adverse pregnancy outcomes	• Pregnant women <20 wk to delivery were given 2 doses of D₃ as supplement capsules• Treatment doses: 10 µg/d or 50 µg/d D₃ (400 or 2000 IU D₃/d)	Higher vitamin D₃ supplementation caused an increase in serum 25-OH-D₃ concentration; increased the peripheral blood IL-10 regulatory CD4⁺ T cell percentage; vitamin D supplement impacts on increasing regulatory T cell concentrations could reduce inflammation associated with pregnancy	(126)
Vitamin D measurements
♂ + ♀	Examined exogenous HT effects on 25-OH-D and DBP in trans individuals	• Transwomen and transmen received exogenous HT for 3 mo• Baseline and 3 mo serum samples were collected and total 25-OH-D, free 25-OH-D, albumin, and DBP were measured	HT did not affect total 25-OH-D concentration in transwomen and transmen; transwomen trended towards an increase in DBP; trans individuals receiving HT does not affect vitamin D status assessments	(113) ¹
♂	Quantified the relation with D₃ input and serum 25-OH-D₃ concentration during winter months in men	• Men from Omaha, NE, were randomly assigned a treatment group and given a daily supplement in tablet form• Treatments were: placebo, supplemental D₃ (25 µg), and 1 or 2 tablets containing 125 µg D₃	Serum 25-OH-D₃ was increased by D₃ dose amount; data suggests that average daily vitamin D intake should be ∼5000 IU/d or 125 µg/d to maintain serum 25-OH-D₃ during winter months	(54)
Vitamin D receptor
♂	Determined VDR and 1α-OHase were expressed in human brain tissue	• Human brain tissue from 5 men, free of any psychopathology or substance abuse• Tissues were sectioned and stained with primary antibody for VDR and secondary antibodies for VDR or 1α-OHase	VDR is widespread throughout brain tissue except in layers in the cerebellum; 1α-OHase is expressed in the same regions as VDR, including the cerebellar layers that VDR was not expressed in	(131)

Trans individuals in this study are on exogenous hormonal treatment.

Value of dietary vitamin D₃ with broiler chicken production

Broiler chickens (grown for meat) have been thoroughly used for vitamin-D-related studies to elucidate specific impacts of vitamin D intake on physiology and metabolism. Studies with broilers can also be designed to control for sunlight exposure or monitoring feed intake (Table 2). Researchers can examine nutrient effects on metabolic relations in broilers by measuring growth performance parameters like breast muscle yield. Despite having low utilization of D₂ (14, 132), there are significant implications for researching vitamin D effects using chickens. The poultry industry is interested in reducing tibial dyschondroplasia (TD) in fast-growing broilers. TD occurs in fast-growing avian species and is a lesion in which the growth plate of the tibia head is avascular and is not mineralized causing bowing of the tibiotarsus and lameness of the bird (133, 134). Increasing dietary vitamin D₃ with increased dietary Ca has been observed to reduce the incidence and severity of TD in young broilers (135–137) (Table 2). There are studies that have examined vitamin D₃ supplementation with other nutrients: strontium supplementation reduced body weight gain (138) and adding D₃ to diets with increased P and microbial phytase improved P and Ca utilization (139) (Table 2).

TABLE 2

Summary of selected studies involving broiler chickens, vitamin D, and their outcomes

Chicken strain and sex	Objective	Treatment regimen	Research findings	Refs
Tibial dyschondroplasia (TD)
Peterson × ArborAcre ♂	Compared and contrasted different D₃ metabolite supplementation with preventing TD	• 7 treatments involving different vitamin D isoforms• 0.1–10.0 µg vitamin D isoform/kg of diet	None of the diets were effective at 0.1 or 1.0 µg/kg at reducing TD severity or incidence; diets effective at higher concentrations, except diets with D₃ and 24,25-(OH)₂-D₃ supplementation	(135)
Ross 308 ♂	Examined how different concentrations of dietary vitamin D₃ with different concentrations of calcium, available phosphorus, and vitamin A, would affect TD incidence	• Dietary D₃ concentrations: 5, 20, 125, and 250 µg D₃/kg of diet	Diets with higher concentrations of vitamin D₃ and optimal dietary calcium and phosphorus concentrations can significantly reduce TD incidence	(136)
Cobb 500 ♂	Compared and contrasted different D₃ metabolite supplementation with preventing TD	• Dietary vitamin D₃ or 25-OH-D₃ concentrations ranged from 3.13, 6.25, 12.5, 25.0, 50.0, and 100.0 µg vitamin D isoform/kg of diet	25-D₃ reduced incidence and severity of TD; increasing concentrations of vitamin D also reduced incidence	(137)
Ross × Ross ♀	Examined maternal vitamin D₃ effects on performance, leg pathology, and bone quality of broiler chicks	• Broiler breeder hens fed diets containing 6.25 or 50.0 µg D₃/kg of diet	Hens fed the 50.0 µg D₃ diet, resulted in chicks that had lower TD incidence scores; chicks from later hatches, regardless of maternal diet, had reduced TD scores	(140)
Genetic lines from Auburn University ♂ + ♀	Determined the response of 25-OH-D₃ in broiler chicks between 2 lines selected for high and low incidence of TD	• Diets comprised basal D₃ (69 µg/kg) plus 25-OH-D₃ (0, 69, and 345 µg/kg)	Supplemented 25-OH-D₃ had no effect on high TD line, but decreased TD incidence in low TD line	(141) ¹
Peterson × ArborAcre ♂	Determined how disulfuram affected vitamin D₃, 25-OH-D₃, and 1,25-(OH)₂-D₃ on TD development in broiler chicks	• Basal dietary D₃ concentration: 27.5 µg/kg• 25-OH-D₃ and 1,25-(OH)₂-D₃ supplementation concentrations: 10 µg/kg	Chicks fed diets containing D₃, 25-OH-D₃, or 1,25-(OH)₂-D₃ supplementation, and disulfiram, had reduced body weight and increased TD incidence	(142)
The influence of dietary vitamin D on phosphorus utilization
Peterson × ArborAcre ♂	Examined how supplemental phytase, vitamin D₃, and dietary Ca:tP would affect utilization of phytate phosphorus and calcium	• Dietary vitamin D₃ concentrations: 66 and 660 µg/kg; 6600 µg/kg was also used without phytase	Diets containing 600 µg/kg of D₃, phytase and between 1.1:1 and 1.4:1 Ca:tP ratio were most optimal for growth performance and calcium and phosphorus utilization	(139)
Commercial, notstated, ♂ + ♀	Determined effects of multiple Ca:P ratios in addition to different concentrations of vitamin D₃ on phosphorus utilization in broiler chicks	• Dietary vitamin D₃ concentrations: 2.5, 5.0, and 10.0 µg/kg for Exp. 1• Dietary vitamin D₃ concentrations: 5.0, 10.0, and 20.0 µg/kg for Exp. 2	Increased dietary vitamin D₃ concentrations led to increased body weight and bone ash; however, the Ca:P ratio was more correlated to body weight and bone ash	(143)
No UV light/exposure
Commercial, notstated, ♂	Determined vitamin D₃ requirement of broiler chicks housed in UV-less environment	• Exp. 2 D₃ concentration: 0, 1.25, 2.50, and 5.0 µg/kg• Exp. 3 D₃ concentration: 0, 5.0, 10.0, and 20.0 µg/kg	Without UV light, there was 77% incidence of rickets in chicks fed diets containing 5.0 µg D₃ compared to 20% when chicks received UV light	(144) ²
Peterson x ArborAcre ♂	Determined if dietary 1,25-(OH)₂-D₃ can reduce vitamin D deficiency effects in broiler chicks if there is no UV light	• Dietary D₃ concentrations ranged from 0, 5.0, 27.5, and 50.0 µg/kg• Dietary 1,25-(OH)₂-D₃ concentrations were 0 and 10.0 µg/kg	Dietary D₃ supplementation concentration of 27.5 µg/kg led to increased tibia bone ash in chicks without UV light; adding 10 µg 1,25-(OH)₂-D₃/kg of diet, was more effective than D₃ in reducing TD incidence and severity	(145)
Dietary vitamin D interaction with other nutrients
Ross 308 ♂	Examined strontium and vitamin D₃ interactive effects in broilers	• Dietary vitamin D₃ concentrations: 125 and 250 µg/kg• Dietary strontium concentrations: 0, 400, 800, and 1200 µg/kg	Higher concentrations of strontium caused a decrease in body weight gain and feed conversion ratio; however, the negative effect is reduced by higher concentrations of vitamin D₃	(138)
Ross (strain # notstated) ♂	Examined dietary effects of different concentrations of D₃, 1α-OH-D₃, 25-OH-D₃, 1,25-(OH)₂-D₃, and vitamin C on TD incidence and severity in broiler chicks	• 75 µg D₃/kg of diet was control diet• 25-OH-D₃ diets: 75 or 250 µg/kg• 5 µg 1α-OH-D₃ + control	Chicks fed 25-OH-D₃ had much lower TD incidence (10%) compared to chicks fed D₃ (65%); adding ascorbic acid had no effect on TD incidence	(146)
Ross × Ross ♂	Determined interactive dietary effects of vitamin A with D₃, 25-OH-D₃, and 1,25-(OH)₂-D₃ and if high concentrations of vitamin A can prevent vitamin D toxicity in broiler chicks	• Vitamin A supplementation concentrations: 450 and 13,500 µg/kg of diet• D₃ and 25-OH-D₃ supplementation concentrations: 0, 5, 10, 20, 40, and 80 µg/kg of diet	Chicks fed diets containing 13,500 µg vitamin A, had a linear decrease in rickets incidence when dietary D₃ concentration increased; 25-OH-D₃ and 1,25-(OH)₂-D₃ were more effective in reducing rickets	(147)
1α-OH-D₃ efficacy
Ross 308 ♂	Determined relative biological value of 1α-OH-D₃ to 25-OH-D₃ in broiler diet	• Dietary 25-OH-D₃ concentrations: 0, 1.25, 2.5, 5.0, and 10.0 µg/kg• Dietary 1α-OH-D₃ concentrations: 0.625, 1.25, 2.5, and 5.0 µg/kg	Relative biological value for 1α-OH-D₃ to 25-OH-D₃ is 202 to 267% for growth performance and bone mineralization	(148)
Ross × Ross ♂ + ♀	Evaluated 1α-OH-D₃ efficacy in relation to vitamin D₃ in broiler chicks' growth performance	• Dietary D₃ concentrations: 2.5, 5.0, 10.0, 20.0, and 40.0 µg/kg• Dietary 1α-OH-D₃ concentrations: 0.625, 1.25, 2.5, 5, and 10.0 µg/kg	1α-OH-D₃ can achieve vitamin D adequacy in broilers without UV light and is ∼8× as effective as D₃ on weight basis	(149) ³

Chicken strain and sex	Objective	Treatment regimen	Research findings	Refs
Tibial dyschondroplasia (TD)
Peterson × ArborAcre ♂	Compared and contrasted different D₃ metabolite supplementation with preventing TD	• 7 treatments involving different vitamin D isoforms• 0.1–10.0 µg vitamin D isoform/kg of diet	None of the diets were effective at 0.1 or 1.0 µg/kg at reducing TD severity or incidence; diets effective at higher concentrations, except diets with D₃ and 24,25-(OH)₂-D₃ supplementation	(135)
Ross 308 ♂	Examined how different concentrations of dietary vitamin D₃ with different concentrations of calcium, available phosphorus, and vitamin A, would affect TD incidence	• Dietary D₃ concentrations: 5, 20, 125, and 250 µg D₃/kg of diet	Diets with higher concentrations of vitamin D₃ and optimal dietary calcium and phosphorus concentrations can significantly reduce TD incidence	(136)
Cobb 500 ♂	Compared and contrasted different D₃ metabolite supplementation with preventing TD	• Dietary vitamin D₃ or 25-OH-D₃ concentrations ranged from 3.13, 6.25, 12.5, 25.0, 50.0, and 100.0 µg vitamin D isoform/kg of diet	25-D₃ reduced incidence and severity of TD; increasing concentrations of vitamin D also reduced incidence	(137)
Ross × Ross ♀	Examined maternal vitamin D₃ effects on performance, leg pathology, and bone quality of broiler chicks	• Broiler breeder hens fed diets containing 6.25 or 50.0 µg D₃/kg of diet	Hens fed the 50.0 µg D₃ diet, resulted in chicks that had lower TD incidence scores; chicks from later hatches, regardless of maternal diet, had reduced TD scores	(140)
Genetic lines from Auburn University ♂ + ♀	Determined the response of 25-OH-D₃ in broiler chicks between 2 lines selected for high and low incidence of TD	• Diets comprised basal D₃ (69 µg/kg) plus 25-OH-D₃ (0, 69, and 345 µg/kg)	Supplemented 25-OH-D₃ had no effect on high TD line, but decreased TD incidence in low TD line	(141) ¹
Peterson × ArborAcre ♂	Determined how disulfuram affected vitamin D₃, 25-OH-D₃, and 1,25-(OH)₂-D₃ on TD development in broiler chicks	• Basal dietary D₃ concentration: 27.5 µg/kg• 25-OH-D₃ and 1,25-(OH)₂-D₃ supplementation concentrations: 10 µg/kg	Chicks fed diets containing D₃, 25-OH-D₃, or 1,25-(OH)₂-D₃ supplementation, and disulfiram, had reduced body weight and increased TD incidence	(142)
The influence of dietary vitamin D on phosphorus utilization
Peterson × ArborAcre ♂	Examined how supplemental phytase, vitamin D₃, and dietary Ca:tP would affect utilization of phytate phosphorus and calcium	• Dietary vitamin D₃ concentrations: 66 and 660 µg/kg; 6600 µg/kg was also used without phytase	Diets containing 600 µg/kg of D₃, phytase and between 1.1:1 and 1.4:1 Ca:tP ratio were most optimal for growth performance and calcium and phosphorus utilization	(139)
Commercial, notstated, ♂ + ♀	Determined effects of multiple Ca:P ratios in addition to different concentrations of vitamin D₃ on phosphorus utilization in broiler chicks	• Dietary vitamin D₃ concentrations: 2.5, 5.0, and 10.0 µg/kg for Exp. 1• Dietary vitamin D₃ concentrations: 5.0, 10.0, and 20.0 µg/kg for Exp. 2	Increased dietary vitamin D₃ concentrations led to increased body weight and bone ash; however, the Ca:P ratio was more correlated to body weight and bone ash	(143)
No UV light/exposure
Commercial, notstated, ♂	Determined vitamin D₃ requirement of broiler chicks housed in UV-less environment	• Exp. 2 D₃ concentration: 0, 1.25, 2.50, and 5.0 µg/kg• Exp. 3 D₃ concentration: 0, 5.0, 10.0, and 20.0 µg/kg	Without UV light, there was 77% incidence of rickets in chicks fed diets containing 5.0 µg D₃ compared to 20% when chicks received UV light	(144) ²
Peterson x ArborAcre ♂	Determined if dietary 1,25-(OH)₂-D₃ can reduce vitamin D deficiency effects in broiler chicks if there is no UV light	• Dietary D₃ concentrations ranged from 0, 5.0, 27.5, and 50.0 µg/kg• Dietary 1,25-(OH)₂-D₃ concentrations were 0 and 10.0 µg/kg	Dietary D₃ supplementation concentration of 27.5 µg/kg led to increased tibia bone ash in chicks without UV light; adding 10 µg 1,25-(OH)₂-D₃/kg of diet, was more effective than D₃ in reducing TD incidence and severity	(145)
Dietary vitamin D interaction with other nutrients
Ross 308 ♂	Examined strontium and vitamin D₃ interactive effects in broilers	• Dietary vitamin D₃ concentrations: 125 and 250 µg/kg• Dietary strontium concentrations: 0, 400, 800, and 1200 µg/kg	Higher concentrations of strontium caused a decrease in body weight gain and feed conversion ratio; however, the negative effect is reduced by higher concentrations of vitamin D₃	(138)
Ross (strain # notstated) ♂	Examined dietary effects of different concentrations of D₃, 1α-OH-D₃, 25-OH-D₃, 1,25-(OH)₂-D₃, and vitamin C on TD incidence and severity in broiler chicks	• 75 µg D₃/kg of diet was control diet• 25-OH-D₃ diets: 75 or 250 µg/kg• 5 µg 1α-OH-D₃ + control	Chicks fed 25-OH-D₃ had much lower TD incidence (10%) compared to chicks fed D₃ (65%); adding ascorbic acid had no effect on TD incidence	(146)
Ross × Ross ♂	Determined interactive dietary effects of vitamin A with D₃, 25-OH-D₃, and 1,25-(OH)₂-D₃ and if high concentrations of vitamin A can prevent vitamin D toxicity in broiler chicks	• Vitamin A supplementation concentrations: 450 and 13,500 µg/kg of diet• D₃ and 25-OH-D₃ supplementation concentrations: 0, 5, 10, 20, 40, and 80 µg/kg of diet	Chicks fed diets containing 13,500 µg vitamin A, had a linear decrease in rickets incidence when dietary D₃ concentration increased; 25-OH-D₃ and 1,25-(OH)₂-D₃ were more effective in reducing rickets	(147)
1α-OH-D₃ efficacy
Ross 308 ♂	Determined relative biological value of 1α-OH-D₃ to 25-OH-D₃ in broiler diet	• Dietary 25-OH-D₃ concentrations: 0, 1.25, 2.5, 5.0, and 10.0 µg/kg• Dietary 1α-OH-D₃ concentrations: 0.625, 1.25, 2.5, and 5.0 µg/kg	Relative biological value for 1α-OH-D₃ to 25-OH-D₃ is 202 to 267% for growth performance and bone mineralization	(148)
Ross × Ross ♂ + ♀	Evaluated 1α-OH-D₃ efficacy in relation to vitamin D₃ in broiler chicks' growth performance	• Dietary D₃ concentrations: 2.5, 5.0, 10.0, 20.0, and 40.0 µg/kg• Dietary 1α-OH-D₃ concentrations: 0.625, 1.25, 2.5, 5, and 10.0 µg/kg	1α-OH-D₃ can achieve vitamin D adequacy in broilers without UV light and is ∼8× as effective as D₃ on weight basis	(149) ³

Strain not described, but the lines were developed and described in (141).

Experiment 1 of (144) utilized Arm-a-Lite^® to determine if fluorescent light was blocked so vitamin D intake was solely from the diet.

This study used 1α-OH-D₃ from 2 different suppliers that had different purity grades; however, they were diluted to equal dilutions when prepared for experimental diets.

♂, male; ♀, female; 1α-OH-D₃, 1-α-hydroxycholecalciferol; 1,25-(OH)₂-D₃, 1,25-dihydroxycholecalciferol;

24,25-(OH)₂-D₃, 24,25-dihydroxycholecalciferol; 25-OH-D₃, 25-hydroxycholecalciferol; Ca: P, calcium: phosphorus ratio; Ca: tP, calcium: total phosphorus ratio; UV, ultraviolet.

TABLE 2

Summary of selected studies involving broiler chickens, vitamin D, and their outcomes

Chicken strain and sex	Objective	Treatment regimen	Research findings	Refs
Tibial dyschondroplasia (TD)
Peterson × ArborAcre ♂	Compared and contrasted different D₃ metabolite supplementation with preventing TD	• 7 treatments involving different vitamin D isoforms• 0.1–10.0 µg vitamin D isoform/kg of diet	None of the diets were effective at 0.1 or 1.0 µg/kg at reducing TD severity or incidence; diets effective at higher concentrations, except diets with D₃ and 24,25-(OH)₂-D₃ supplementation	(135)
Ross 308 ♂	Examined how different concentrations of dietary vitamin D₃ with different concentrations of calcium, available phosphorus, and vitamin A, would affect TD incidence	• Dietary D₃ concentrations: 5, 20, 125, and 250 µg D₃/kg of diet	Diets with higher concentrations of vitamin D₃ and optimal dietary calcium and phosphorus concentrations can significantly reduce TD incidence	(136)
Cobb 500 ♂	Compared and contrasted different D₃ metabolite supplementation with preventing TD	• Dietary vitamin D₃ or 25-OH-D₃ concentrations ranged from 3.13, 6.25, 12.5, 25.0, 50.0, and 100.0 µg vitamin D isoform/kg of diet	25-D₃ reduced incidence and severity of TD; increasing concentrations of vitamin D also reduced incidence	(137)
Ross × Ross ♀	Examined maternal vitamin D₃ effects on performance, leg pathology, and bone quality of broiler chicks	• Broiler breeder hens fed diets containing 6.25 or 50.0 µg D₃/kg of diet	Hens fed the 50.0 µg D₃ diet, resulted in chicks that had lower TD incidence scores; chicks from later hatches, regardless of maternal diet, had reduced TD scores	(140)
Genetic lines from Auburn University ♂ + ♀	Determined the response of 25-OH-D₃ in broiler chicks between 2 lines selected for high and low incidence of TD	• Diets comprised basal D₃ (69 µg/kg) plus 25-OH-D₃ (0, 69, and 345 µg/kg)	Supplemented 25-OH-D₃ had no effect on high TD line, but decreased TD incidence in low TD line	(141) ¹
Peterson × ArborAcre ♂	Determined how disulfuram affected vitamin D₃, 25-OH-D₃, and 1,25-(OH)₂-D₃ on TD development in broiler chicks	• Basal dietary D₃ concentration: 27.5 µg/kg• 25-OH-D₃ and 1,25-(OH)₂-D₃ supplementation concentrations: 10 µg/kg	Chicks fed diets containing D₃, 25-OH-D₃, or 1,25-(OH)₂-D₃ supplementation, and disulfiram, had reduced body weight and increased TD incidence	(142)
The influence of dietary vitamin D on phosphorus utilization
Peterson × ArborAcre ♂	Examined how supplemental phytase, vitamin D₃, and dietary Ca:tP would affect utilization of phytate phosphorus and calcium	• Dietary vitamin D₃ concentrations: 66 and 660 µg/kg; 6600 µg/kg was also used without phytase	Diets containing 600 µg/kg of D₃, phytase and between 1.1:1 and 1.4:1 Ca:tP ratio were most optimal for growth performance and calcium and phosphorus utilization	(139)
Commercial, notstated, ♂ + ♀	Determined effects of multiple Ca:P ratios in addition to different concentrations of vitamin D₃ on phosphorus utilization in broiler chicks	• Dietary vitamin D₃ concentrations: 2.5, 5.0, and 10.0 µg/kg for Exp. 1• Dietary vitamin D₃ concentrations: 5.0, 10.0, and 20.0 µg/kg for Exp. 2	Increased dietary vitamin D₃ concentrations led to increased body weight and bone ash; however, the Ca:P ratio was more correlated to body weight and bone ash	(143)
No UV light/exposure
Commercial, notstated, ♂	Determined vitamin D₃ requirement of broiler chicks housed in UV-less environment	• Exp. 2 D₃ concentration: 0, 1.25, 2.50, and 5.0 µg/kg• Exp. 3 D₃ concentration: 0, 5.0, 10.0, and 20.0 µg/kg	Without UV light, there was 77% incidence of rickets in chicks fed diets containing 5.0 µg D₃ compared to 20% when chicks received UV light	(144) ²
Peterson x ArborAcre ♂	Determined if dietary 1,25-(OH)₂-D₃ can reduce vitamin D deficiency effects in broiler chicks if there is no UV light	• Dietary D₃ concentrations ranged from 0, 5.0, 27.5, and 50.0 µg/kg• Dietary 1,25-(OH)₂-D₃ concentrations were 0 and 10.0 µg/kg	Dietary D₃ supplementation concentration of 27.5 µg/kg led to increased tibia bone ash in chicks without UV light; adding 10 µg 1,25-(OH)₂-D₃/kg of diet, was more effective than D₃ in reducing TD incidence and severity	(145)
Dietary vitamin D interaction with other nutrients
Ross 308 ♂	Examined strontium and vitamin D₃ interactive effects in broilers	• Dietary vitamin D₃ concentrations: 125 and 250 µg/kg• Dietary strontium concentrations: 0, 400, 800, and 1200 µg/kg	Higher concentrations of strontium caused a decrease in body weight gain and feed conversion ratio; however, the negative effect is reduced by higher concentrations of vitamin D₃	(138)
Ross (strain # notstated) ♂	Examined dietary effects of different concentrations of D₃, 1α-OH-D₃, 25-OH-D₃, 1,25-(OH)₂-D₃, and vitamin C on TD incidence and severity in broiler chicks	• 75 µg D₃/kg of diet was control diet• 25-OH-D₃ diets: 75 or 250 µg/kg• 5 µg 1α-OH-D₃ + control	Chicks fed 25-OH-D₃ had much lower TD incidence (10%) compared to chicks fed D₃ (65%); adding ascorbic acid had no effect on TD incidence	(146)
Ross × Ross ♂	Determined interactive dietary effects of vitamin A with D₃, 25-OH-D₃, and 1,25-(OH)₂-D₃ and if high concentrations of vitamin A can prevent vitamin D toxicity in broiler chicks	• Vitamin A supplementation concentrations: 450 and 13,500 µg/kg of diet• D₃ and 25-OH-D₃ supplementation concentrations: 0, 5, 10, 20, 40, and 80 µg/kg of diet	Chicks fed diets containing 13,500 µg vitamin A, had a linear decrease in rickets incidence when dietary D₃ concentration increased; 25-OH-D₃ and 1,25-(OH)₂-D₃ were more effective in reducing rickets	(147)
1α-OH-D₃ efficacy
Ross 308 ♂	Determined relative biological value of 1α-OH-D₃ to 25-OH-D₃ in broiler diet	• Dietary 25-OH-D₃ concentrations: 0, 1.25, 2.5, 5.0, and 10.0 µg/kg• Dietary 1α-OH-D₃ concentrations: 0.625, 1.25, 2.5, and 5.0 µg/kg	Relative biological value for 1α-OH-D₃ to 25-OH-D₃ is 202 to 267% for growth performance and bone mineralization	(148)
Ross × Ross ♂ + ♀	Evaluated 1α-OH-D₃ efficacy in relation to vitamin D₃ in broiler chicks' growth performance	• Dietary D₃ concentrations: 2.5, 5.0, 10.0, 20.0, and 40.0 µg/kg• Dietary 1α-OH-D₃ concentrations: 0.625, 1.25, 2.5, 5, and 10.0 µg/kg	1α-OH-D₃ can achieve vitamin D adequacy in broilers without UV light and is ∼8× as effective as D₃ on weight basis	(149) ³

Chicken strain and sex	Objective	Treatment regimen	Research findings	Refs
Tibial dyschondroplasia (TD)
Peterson × ArborAcre ♂	Compared and contrasted different D₃ metabolite supplementation with preventing TD	• 7 treatments involving different vitamin D isoforms• 0.1–10.0 µg vitamin D isoform/kg of diet	None of the diets were effective at 0.1 or 1.0 µg/kg at reducing TD severity or incidence; diets effective at higher concentrations, except diets with D₃ and 24,25-(OH)₂-D₃ supplementation	(135)
Ross 308 ♂	Examined how different concentrations of dietary vitamin D₃ with different concentrations of calcium, available phosphorus, and vitamin A, would affect TD incidence	• Dietary D₃ concentrations: 5, 20, 125, and 250 µg D₃/kg of diet	Diets with higher concentrations of vitamin D₃ and optimal dietary calcium and phosphorus concentrations can significantly reduce TD incidence	(136)
Cobb 500 ♂	Compared and contrasted different D₃ metabolite supplementation with preventing TD	• Dietary vitamin D₃ or 25-OH-D₃ concentrations ranged from 3.13, 6.25, 12.5, 25.0, 50.0, and 100.0 µg vitamin D isoform/kg of diet	25-D₃ reduced incidence and severity of TD; increasing concentrations of vitamin D also reduced incidence	(137)
Ross × Ross ♀	Examined maternal vitamin D₃ effects on performance, leg pathology, and bone quality of broiler chicks	• Broiler breeder hens fed diets containing 6.25 or 50.0 µg D₃/kg of diet	Hens fed the 50.0 µg D₃ diet, resulted in chicks that had lower TD incidence scores; chicks from later hatches, regardless of maternal diet, had reduced TD scores	(140)
Genetic lines from Auburn University ♂ + ♀	Determined the response of 25-OH-D₃ in broiler chicks between 2 lines selected for high and low incidence of TD	• Diets comprised basal D₃ (69 µg/kg) plus 25-OH-D₃ (0, 69, and 345 µg/kg)	Supplemented 25-OH-D₃ had no effect on high TD line, but decreased TD incidence in low TD line	(141) ¹
Peterson × ArborAcre ♂	Determined how disulfuram affected vitamin D₃, 25-OH-D₃, and 1,25-(OH)₂-D₃ on TD development in broiler chicks	• Basal dietary D₃ concentration: 27.5 µg/kg• 25-OH-D₃ and 1,25-(OH)₂-D₃ supplementation concentrations: 10 µg/kg	Chicks fed diets containing D₃, 25-OH-D₃, or 1,25-(OH)₂-D₃ supplementation, and disulfiram, had reduced body weight and increased TD incidence	(142)
The influence of dietary vitamin D on phosphorus utilization
Peterson × ArborAcre ♂	Examined how supplemental phytase, vitamin D₃, and dietary Ca:tP would affect utilization of phytate phosphorus and calcium	• Dietary vitamin D₃ concentrations: 66 and 660 µg/kg; 6600 µg/kg was also used without phytase	Diets containing 600 µg/kg of D₃, phytase and between 1.1:1 and 1.4:1 Ca:tP ratio were most optimal for growth performance and calcium and phosphorus utilization	(139)
Commercial, notstated, ♂ + ♀	Determined effects of multiple Ca:P ratios in addition to different concentrations of vitamin D₃ on phosphorus utilization in broiler chicks	• Dietary vitamin D₃ concentrations: 2.5, 5.0, and 10.0 µg/kg for Exp. 1• Dietary vitamin D₃ concentrations: 5.0, 10.0, and 20.0 µg/kg for Exp. 2	Increased dietary vitamin D₃ concentrations led to increased body weight and bone ash; however, the Ca:P ratio was more correlated to body weight and bone ash	(143)
No UV light/exposure
Commercial, notstated, ♂	Determined vitamin D₃ requirement of broiler chicks housed in UV-less environment	• Exp. 2 D₃ concentration: 0, 1.25, 2.50, and 5.0 µg/kg• Exp. 3 D₃ concentration: 0, 5.0, 10.0, and 20.0 µg/kg	Without UV light, there was 77% incidence of rickets in chicks fed diets containing 5.0 µg D₃ compared to 20% when chicks received UV light	(144) ²
Peterson x ArborAcre ♂	Determined if dietary 1,25-(OH)₂-D₃ can reduce vitamin D deficiency effects in broiler chicks if there is no UV light	• Dietary D₃ concentrations ranged from 0, 5.0, 27.5, and 50.0 µg/kg• Dietary 1,25-(OH)₂-D₃ concentrations were 0 and 10.0 µg/kg	Dietary D₃ supplementation concentration of 27.5 µg/kg led to increased tibia bone ash in chicks without UV light; adding 10 µg 1,25-(OH)₂-D₃/kg of diet, was more effective than D₃ in reducing TD incidence and severity	(145)
Dietary vitamin D interaction with other nutrients
Ross 308 ♂	Examined strontium and vitamin D₃ interactive effects in broilers	• Dietary vitamin D₃ concentrations: 125 and 250 µg/kg• Dietary strontium concentrations: 0, 400, 800, and 1200 µg/kg	Higher concentrations of strontium caused a decrease in body weight gain and feed conversion ratio; however, the negative effect is reduced by higher concentrations of vitamin D₃	(138)
Ross (strain # notstated) ♂	Examined dietary effects of different concentrations of D₃, 1α-OH-D₃, 25-OH-D₃, 1,25-(OH)₂-D₃, and vitamin C on TD incidence and severity in broiler chicks	• 75 µg D₃/kg of diet was control diet• 25-OH-D₃ diets: 75 or 250 µg/kg• 5 µg 1α-OH-D₃ + control	Chicks fed 25-OH-D₃ had much lower TD incidence (10%) compared to chicks fed D₃ (65%); adding ascorbic acid had no effect on TD incidence	(146)
Ross × Ross ♂	Determined interactive dietary effects of vitamin A with D₃, 25-OH-D₃, and 1,25-(OH)₂-D₃ and if high concentrations of vitamin A can prevent vitamin D toxicity in broiler chicks	• Vitamin A supplementation concentrations: 450 and 13,500 µg/kg of diet• D₃ and 25-OH-D₃ supplementation concentrations: 0, 5, 10, 20, 40, and 80 µg/kg of diet	Chicks fed diets containing 13,500 µg vitamin A, had a linear decrease in rickets incidence when dietary D₃ concentration increased; 25-OH-D₃ and 1,25-(OH)₂-D₃ were more effective in reducing rickets	(147)
1α-OH-D₃ efficacy
Ross 308 ♂	Determined relative biological value of 1α-OH-D₃ to 25-OH-D₃ in broiler diet	• Dietary 25-OH-D₃ concentrations: 0, 1.25, 2.5, 5.0, and 10.0 µg/kg• Dietary 1α-OH-D₃ concentrations: 0.625, 1.25, 2.5, and 5.0 µg/kg	Relative biological value for 1α-OH-D₃ to 25-OH-D₃ is 202 to 267% for growth performance and bone mineralization	(148)
Ross × Ross ♂ + ♀	Evaluated 1α-OH-D₃ efficacy in relation to vitamin D₃ in broiler chicks' growth performance	• Dietary D₃ concentrations: 2.5, 5.0, 10.0, 20.0, and 40.0 µg/kg• Dietary 1α-OH-D₃ concentrations: 0.625, 1.25, 2.5, 5, and 10.0 µg/kg	1α-OH-D₃ can achieve vitamin D adequacy in broilers without UV light and is ∼8× as effective as D₃ on weight basis	(149) ³

Strain not described, but the lines were developed and described in (141).

Experiment 1 of (144) utilized Arm-a-Lite^® to determine if fluorescent light was blocked so vitamin D intake was solely from the diet.

This study used 1α-OH-D₃ from 2 different suppliers that had different purity grades; however, they were diluted to equal dilutions when prepared for experimental diets.

♂, male; ♀, female; 1α-OH-D₃, 1-α-hydroxycholecalciferol; 1,25-(OH)₂-D₃, 1,25-dihydroxycholecalciferol;

24,25-(OH)₂-D₃, 24,25-dihydroxycholecalciferol; 25-OH-D₃, 25-hydroxycholecalciferol; Ca: P, calcium: phosphorus ratio; Ca: tP, calcium: total phosphorus ratio; UV, ultraviolet.

Exploring the dietary intake of vitamin D with other nutrients can cause variation, but it will also help address vitamin D insufficiency with regards to how food sources can affect vitamin D status. Many studies examining dietary D₃ effects in broilers have repeatedly shown improved bone health (135, 137, 140, 143, 144) (Table 2). Chicken feed can be supplemented with 25-OH-D₃ and has been very effective in reducing TD compared with broilers only fed D₃ (141, 146). Studies involving broilers being fed 1,25-(OH)₂-D₃ reported an increase in bone ash and plasma Ca, and reduced the incidence of rickets (142, 145, 147). 1α-OH-D₃ has been observed to have better bioefficacy than 25-OH-D₃ when used as an additive in broiler feed (148) and it is ∼8× more effective than D₃ (149) (Table 2). Broiler chicks fed diets with higher concentrations of Ca and supplemented with 1α-OH-D₃ had a lower plasma 25-OH-D₃ concentration (150). It has also been suggested that due to the high bioavailability of 1α-OH-D₃ in a synthetic mixed micelle with human intestinal cells (Caco-2), 1α-OH-D₃ can be used to treat severe vitamin D deficiency (151).

Effects of dietary vitamin D₃ with laying hens in production

Laying hens provide eggs for consumption and their production performance is an accessible trait to quantify dietary or supplementary effects (Table 3). There was improved bone structure in laying hens that were fed vitamin D₃, 25-OH-D₃ or 1,25-(OH)₂-D₃ (152, 153). However, Ca intake is more important for egg production and quality (154, 155). While most studies involving vitamin D₃ with laying hens focused on egg quality (Table 3), 1 study explored how vitamin D₃ affected the hen ovary during follicle development (156). Enriching laying hen diets with specific vitamins has a direct impact on vitamin content in the egg yolk.

Eggs from laying hens have a powerful value for addressing nutrient deficiencies, especially for lipid-related nutrients (157). The fatty acid profiles of egg yolk are directly related to carotenoids and the diet quality of a hen (158). When laying hens were fed layer-breeder diets with supplemented vitamin A, the vitamin A concentration in the egg yolk was greatly increased (159). Increasing concentrations of vitamin E in a laying hen diet also increases vitamin E content in the egg yolk (160) (Table 3). It should be noted that competitive antagonism for intestinal absorption can occur between fat-soluble vitamins when dietary supplements are provided to hens (161, 162). However, there are possibilities of creating specific value-added eggs to address specific vitamin needs by feeding hens with supplemental concentrations of a particular vitamin in their diet (157).

The egg yolk vitamin D₃ content can reach a concentration that will meet daily vitamin D demands if a hen is fed a diet with high concentrations of vitamin D₃ (163) (Table 3). Mattila et al. (163) reported how laying hens fed a diet with the highest vitamin D₃ content (216 µg D₃/kg of feed) resulted in an egg yolk containing 23 µg D₃/100 g and 1.5 µg 25-OH-D₃/100 g. Eating 1 egg from those laying hens could easily achieve the vitamin D RDA for adult men and women (15 µg/d or 600 IU/d) in the USA (164, 165). Although there has been some research examining value-added eggs, when hens were fed diets with high concentrations of dietary vitamin D₃ (163, 166–168) (Table 3), there are implications for exploring the feasibility of value-added eggs that can be a food supply to address areas of nutrient demands in locations that are geographically poor in sunlight and have little access to other dairy products or fortified foods. There are positive implications for exploring how vitamin-D-enriched eggs can improve nutritional status of at-risk populations such as the elderly.

Vitamin D deficiency and toxicity in humans and chickens

Even though vitamin D is stored in tissues, vitamin D deficiency can occur under specific conditions. An animal consuming a vitamin-D-poor diet and not exposed to sunlight will eventually express signs of deficiency such as rickets for young, growing animals and an increased risk of bone fractures or muscle weakness (169–171). Elderly men and women are most susceptible to vitamin D deficiency (172, 130) (Table 1); however, children and young adults can also be at risk of vitamin D deficiency if they have a vitamin-D-poor diet or are in geographical locations with poor sunlight exposure (173–175). Vitamin D deficiency can also occur if there is a genetic defect within the VDR (176). Lack of signaling from 1,25-(OH)₂-D binding to VDR also affects various genes responsible for cell proliferation and may influence cancer incidence (177–179).

TABLE 3

Summary of selected studies involving layer pullets/hens, vitamin supplementation on egg properties, and their outcomes

Chicken strain	Objective	Treatment regimen	Research findings	Refs
Dietary vitamin D supplementation impacts on vitamin D content in egg yolk
Lohmann White	Examined how vitamin D₃ is effectively transferred from feed to egg yolk and how supplemental D₃ affects 25-OH-D₃ in the egg yolk	• Dietary vitamin D₃ concentrations: 26.6, 62.4, and 216.0 µg/kg	When D₃ content in feed was increased from 62.4 to 216 µg/kg, there was a 7-fold increase in egg yolk D₃ and 1.5-fold increase in 25-OH-D₃	(163)
Lohmann White	Examined how quickly and effectively, high concentrations of vitamin D₃ supplementation can transfer from feed to the egg yolk	• Basal dietary vitamin D₃ concentrations: 43 and 107 µg/kg• Experimental dietary vitamin D₃ concentrations: 280 and 300 µg/kg	Vitamin D content in egg yolk achieved a peak (30 µg D₃/100 g yolk weight) around 8–13 d from the start of the experimental high D₃ diets; feeding 1708.7 µg D₃/kg diet did not affect eggshell strength or harm the hens	(166)
Lohmann LSL White	Assessed dietary effects of vitamin D₂ and D₃ supplementation during entire egg-laying period	• Dietary D₃ concentrations: 62.5, 150.0, 375.0 µg/kg• Diets with D₂ contained 62.5 µg D₃ + 150.0 or 375.0 µg D₂	Dietary D₃ was more effective with increasing vitamin D content in the egg yolk compared to D₂; no negative effect of dietary supplementation of D₂ or D₃ on body weight or tibia strength	(167)
Hy-Line W-36	Determined the dietary effects of various concentrations of vitamin D₃ supplementation on laying hen production performance, bone health, and egg quality	• Dietary D₃ concentrations: 42.0, 208.7, 458.7, 875.35, and 1708.7 µg/kg	No dietary effect of D₃ supplementation on keel bone damage; increasing dietary vitamin D₃ supplementation concentrations led to increased vitamin D₃ content in the egg yolk	(168)
Dietary vitamin D supplementation effects on egg production
Hy-Line W-36	Determined if dietary supplementation of vitamin D₃, 1,25-(OH)₂-D₃, and 1α-OH-D₃ improved eggshell quality, egg production, and tibia strength	• Dietary 1α-OH-D₃ and 1,25-(OH)₂-D₃ concentrations for Exp. 1: 0, 0.75, 1.5, 3.0, 4.5 µg/kg• Dietary vitamin D₃ concentrations: 0, 12.5, 25.0, 37.5 µg/kg	1α-OH-D₃ and 1,25-(OH)₂-D₃ did not affect eggshell quality or egg production; increased dietary D₃ concentrations led to quadratically increased serum calcium at oviposition	(152)
Lohmann White	Examined increased dosage of dietary vitamin D₂, D₃, and 25-OH-D₃ on bone mineralization and egg production	• Basal diet contains 75.0 µg D₃/kg of diet• Supplemented vitamin D₂, D₃, and 25-OH-D₃ concentrations added to basal diet: 75.0 and 225.0 µg/kg	No soft tissue calcification was observed in hens fed diets with supplemental vitamin D concentrations; supplement doses did not affect egg quality, egg production, or bone health	(153)
Dietary vitamin supplementation effects on egg yolk content
Hy-Line W-36	Examine dietary effects of different sources of fatty acids and 2 concentrations of vitamin E on lipid profile in eggs	• Vitamin E concentrations: 10.9 and 90.9 mg/kg• Dietary D₃ concentration was 62.5 µg/kg	Fatty acid source influenced yolk lipid profile; interaction between fatty acid source and 90.9 mg of vitamin E/kg of diet, led to increased vitamin E content in egg	(158) ¹
Rhode Island Red	Evaluate dietary vitamin A supplementation on maternal hen on accumulation of vitamins A, E, C, and carotenoids in embryonic liver	• Dietary vitamin A supplementation concentrations: 0, 3, 30, and 120 µg retinol equivalent/g of diet	Egg yolk vitamin A content was increased as dietary vitamin A supplementation increased; however, vitamin E and carotenoid concentrations were reduced as a trade-off	(159) ²
Hy-Line Brown	Determine if dietary vitamin E supplementation in laying hen diets can fortify eggs in dose-dependent response	• Diets contained 40 mg of vitamin E and 0, 50,100, and 200 mg were added supplement concentrations• Dietary D₃ concentration was 75.0 µg/kg	Vitamin E in the egg yolk increased linearly as vitamin E in diet increased	(160) ³
Dietary calcium effects on egg production
Hy-Line W-36and Dekalb XL	Determine if increased dietary macronutrient concentrations, lacking calcium, leads to increased liver fat and affect egg size and production	• Dietary calcium concentrations ranged from 1.0 to 4.1%; there were multiple experiments with different concentrations within that range• Dietary D₃ concentration was 55.0 µg/kg	Lower calcium concentrations led to increased feed intake, body weight, liver weight, and fat pad; although, there was no effect on egg size or production	(154)
Hy-Line W-36	Does calcium and NaHCO₃ supplementation in diets with continuous feed access with 24-h light, lead to improved eggshell quality?	• NaHCO₃ supplementation: 0 or 0.5%; dietary calcium source: ground limestone or 1/3 ground limestone with 2/3 oyster shell• Dietary D₃ concentration was 41.3 µg/kg	Feeding supplementary NaHCO₃ increased egg elasticity and 24-h photoperiod improved eggshell quality	(155)

Chicken strain	Objective	Treatment regimen	Research findings	Refs
Dietary vitamin D supplementation impacts on vitamin D content in egg yolk
Lohmann White	Examined how vitamin D₃ is effectively transferred from feed to egg yolk and how supplemental D₃ affects 25-OH-D₃ in the egg yolk	• Dietary vitamin D₃ concentrations: 26.6, 62.4, and 216.0 µg/kg	When D₃ content in feed was increased from 62.4 to 216 µg/kg, there was a 7-fold increase in egg yolk D₃ and 1.5-fold increase in 25-OH-D₃	(163)
Lohmann White	Examined how quickly and effectively, high concentrations of vitamin D₃ supplementation can transfer from feed to the egg yolk	• Basal dietary vitamin D₃ concentrations: 43 and 107 µg/kg• Experimental dietary vitamin D₃ concentrations: 280 and 300 µg/kg	Vitamin D content in egg yolk achieved a peak (30 µg D₃/100 g yolk weight) around 8–13 d from the start of the experimental high D₃ diets; feeding 1708.7 µg D₃/kg diet did not affect eggshell strength or harm the hens	(166)
Lohmann LSL White	Assessed dietary effects of vitamin D₂ and D₃ supplementation during entire egg-laying period	• Dietary D₃ concentrations: 62.5, 150.0, 375.0 µg/kg• Diets with D₂ contained 62.5 µg D₃ + 150.0 or 375.0 µg D₂	Dietary D₃ was more effective with increasing vitamin D content in the egg yolk compared to D₂; no negative effect of dietary supplementation of D₂ or D₃ on body weight or tibia strength	(167)
Hy-Line W-36	Determined the dietary effects of various concentrations of vitamin D₃ supplementation on laying hen production performance, bone health, and egg quality	• Dietary D₃ concentrations: 42.0, 208.7, 458.7, 875.35, and 1708.7 µg/kg	No dietary effect of D₃ supplementation on keel bone damage; increasing dietary vitamin D₃ supplementation concentrations led to increased vitamin D₃ content in the egg yolk	(168)
Dietary vitamin D supplementation effects on egg production
Hy-Line W-36	Determined if dietary supplementation of vitamin D₃, 1,25-(OH)₂-D₃, and 1α-OH-D₃ improved eggshell quality, egg production, and tibia strength	• Dietary 1α-OH-D₃ and 1,25-(OH)₂-D₃ concentrations for Exp. 1: 0, 0.75, 1.5, 3.0, 4.5 µg/kg• Dietary vitamin D₃ concentrations: 0, 12.5, 25.0, 37.5 µg/kg	1α-OH-D₃ and 1,25-(OH)₂-D₃ did not affect eggshell quality or egg production; increased dietary D₃ concentrations led to quadratically increased serum calcium at oviposition	(152)
Lohmann White	Examined increased dosage of dietary vitamin D₂, D₃, and 25-OH-D₃ on bone mineralization and egg production	• Basal diet contains 75.0 µg D₃/kg of diet• Supplemented vitamin D₂, D₃, and 25-OH-D₃ concentrations added to basal diet: 75.0 and 225.0 µg/kg	No soft tissue calcification was observed in hens fed diets with supplemental vitamin D concentrations; supplement doses did not affect egg quality, egg production, or bone health	(153)
Dietary vitamin supplementation effects on egg yolk content
Hy-Line W-36	Examine dietary effects of different sources of fatty acids and 2 concentrations of vitamin E on lipid profile in eggs	• Vitamin E concentrations: 10.9 and 90.9 mg/kg• Dietary D₃ concentration was 62.5 µg/kg	Fatty acid source influenced yolk lipid profile; interaction between fatty acid source and 90.9 mg of vitamin E/kg of diet, led to increased vitamin E content in egg	(158) ¹
Rhode Island Red	Evaluate dietary vitamin A supplementation on maternal hen on accumulation of vitamins A, E, C, and carotenoids in embryonic liver	• Dietary vitamin A supplementation concentrations: 0, 3, 30, and 120 µg retinol equivalent/g of diet	Egg yolk vitamin A content was increased as dietary vitamin A supplementation increased; however, vitamin E and carotenoid concentrations were reduced as a trade-off	(159) ²
Hy-Line Brown	Determine if dietary vitamin E supplementation in laying hen diets can fortify eggs in dose-dependent response	• Diets contained 40 mg of vitamin E and 0, 50,100, and 200 mg were added supplement concentrations• Dietary D₃ concentration was 75.0 µg/kg	Vitamin E in the egg yolk increased linearly as vitamin E in diet increased	(160) ³
Dietary calcium effects on egg production
Hy-Line W-36and Dekalb XL	Determine if increased dietary macronutrient concentrations, lacking calcium, leads to increased liver fat and affect egg size and production	• Dietary calcium concentrations ranged from 1.0 to 4.1%; there were multiple experiments with different concentrations within that range• Dietary D₃ concentration was 55.0 µg/kg	Lower calcium concentrations led to increased feed intake, body weight, liver weight, and fat pad; although, there was no effect on egg size or production	(154)
Hy-Line W-36	Does calcium and NaHCO₃ supplementation in diets with continuous feed access with 24-h light, lead to improved eggshell quality?	• NaHCO₃ supplementation: 0 or 0.5%; dietary calcium source: ground limestone or 1/3 ground limestone with 2/3 oyster shell• Dietary D₃ concentration was 41.3 µg/kg	Feeding supplementary NaHCO₃ increased egg elasticity and 24-h photoperiod improved eggshell quality	(155)

Vitamin E form was not stated; therefore, we assumed the authors used DL-α-tocopherol.

Article stated the hens were fed a proprietary breeders' wheat-barley-based diet so vitamin D content is not stated; vitamin A form used in the article was retinol-acetate.

Vitamin E form used for dietary supplementation in the study was DL-α-tocopherol.

1α-OH-D₃, 1-α-hydroxycholecalciferol; 1,25-(OH)₂-D₃, 1,25-dihydroxycholecalciferol; 25-OH-D₃, 25-hydroxycholecalciferol; NaHCO₃, sodium bicarbonate.

TABLE 3

Summary of selected studies involving layer pullets/hens, vitamin supplementation on egg properties, and their outcomes

Chicken strain	Objective	Treatment regimen	Research findings	Refs
Dietary vitamin D supplementation impacts on vitamin D content in egg yolk
Lohmann White	Examined how vitamin D₃ is effectively transferred from feed to egg yolk and how supplemental D₃ affects 25-OH-D₃ in the egg yolk	• Dietary vitamin D₃ concentrations: 26.6, 62.4, and 216.0 µg/kg	When D₃ content in feed was increased from 62.4 to 216 µg/kg, there was a 7-fold increase in egg yolk D₃ and 1.5-fold increase in 25-OH-D₃	(163)
Lohmann White	Examined how quickly and effectively, high concentrations of vitamin D₃ supplementation can transfer from feed to the egg yolk	• Basal dietary vitamin D₃ concentrations: 43 and 107 µg/kg• Experimental dietary vitamin D₃ concentrations: 280 and 300 µg/kg	Vitamin D content in egg yolk achieved a peak (30 µg D₃/100 g yolk weight) around 8–13 d from the start of the experimental high D₃ diets; feeding 1708.7 µg D₃/kg diet did not affect eggshell strength or harm the hens	(166)
Lohmann LSL White	Assessed dietary effects of vitamin D₂ and D₃ supplementation during entire egg-laying period	• Dietary D₃ concentrations: 62.5, 150.0, 375.0 µg/kg• Diets with D₂ contained 62.5 µg D₃ + 150.0 or 375.0 µg D₂	Dietary D₃ was more effective with increasing vitamin D content in the egg yolk compared to D₂; no negative effect of dietary supplementation of D₂ or D₃ on body weight or tibia strength	(167)
Hy-Line W-36	Determined the dietary effects of various concentrations of vitamin D₃ supplementation on laying hen production performance, bone health, and egg quality	• Dietary D₃ concentrations: 42.0, 208.7, 458.7, 875.35, and 1708.7 µg/kg	No dietary effect of D₃ supplementation on keel bone damage; increasing dietary vitamin D₃ supplementation concentrations led to increased vitamin D₃ content in the egg yolk	(168)
Dietary vitamin D supplementation effects on egg production
Hy-Line W-36	Determined if dietary supplementation of vitamin D₃, 1,25-(OH)₂-D₃, and 1α-OH-D₃ improved eggshell quality, egg production, and tibia strength	• Dietary 1α-OH-D₃ and 1,25-(OH)₂-D₃ concentrations for Exp. 1: 0, 0.75, 1.5, 3.0, 4.5 µg/kg• Dietary vitamin D₃ concentrations: 0, 12.5, 25.0, 37.5 µg/kg	1α-OH-D₃ and 1,25-(OH)₂-D₃ did not affect eggshell quality or egg production; increased dietary D₃ concentrations led to quadratically increased serum calcium at oviposition	(152)
Lohmann White	Examined increased dosage of dietary vitamin D₂, D₃, and 25-OH-D₃ on bone mineralization and egg production	• Basal diet contains 75.0 µg D₃/kg of diet• Supplemented vitamin D₂, D₃, and 25-OH-D₃ concentrations added to basal diet: 75.0 and 225.0 µg/kg	No soft tissue calcification was observed in hens fed diets with supplemental vitamin D concentrations; supplement doses did not affect egg quality, egg production, or bone health	(153)
Dietary vitamin supplementation effects on egg yolk content
Hy-Line W-36	Examine dietary effects of different sources of fatty acids and 2 concentrations of vitamin E on lipid profile in eggs	• Vitamin E concentrations: 10.9 and 90.9 mg/kg• Dietary D₃ concentration was 62.5 µg/kg	Fatty acid source influenced yolk lipid profile; interaction between fatty acid source and 90.9 mg of vitamin E/kg of diet, led to increased vitamin E content in egg	(158) ¹
Rhode Island Red	Evaluate dietary vitamin A supplementation on maternal hen on accumulation of vitamins A, E, C, and carotenoids in embryonic liver	• Dietary vitamin A supplementation concentrations: 0, 3, 30, and 120 µg retinol equivalent/g of diet	Egg yolk vitamin A content was increased as dietary vitamin A supplementation increased; however, vitamin E and carotenoid concentrations were reduced as a trade-off	(159) ²
Hy-Line Brown	Determine if dietary vitamin E supplementation in laying hen diets can fortify eggs in dose-dependent response	• Diets contained 40 mg of vitamin E and 0, 50,100, and 200 mg were added supplement concentrations• Dietary D₃ concentration was 75.0 µg/kg	Vitamin E in the egg yolk increased linearly as vitamin E in diet increased	(160) ³
Dietary calcium effects on egg production
Hy-Line W-36and Dekalb XL	Determine if increased dietary macronutrient concentrations, lacking calcium, leads to increased liver fat and affect egg size and production	• Dietary calcium concentrations ranged from 1.0 to 4.1%; there were multiple experiments with different concentrations within that range• Dietary D₃ concentration was 55.0 µg/kg	Lower calcium concentrations led to increased feed intake, body weight, liver weight, and fat pad; although, there was no effect on egg size or production	(154)
Hy-Line W-36	Does calcium and NaHCO₃ supplementation in diets with continuous feed access with 24-h light, lead to improved eggshell quality?	• NaHCO₃ supplementation: 0 or 0.5%; dietary calcium source: ground limestone or 1/3 ground limestone with 2/3 oyster shell• Dietary D₃ concentration was 41.3 µg/kg	Feeding supplementary NaHCO₃ increased egg elasticity and 24-h photoperiod improved eggshell quality	(155)

Chicken strain	Objective	Treatment regimen	Research findings	Refs
Dietary vitamin D supplementation impacts on vitamin D content in egg yolk
Lohmann White	Examined how vitamin D₃ is effectively transferred from feed to egg yolk and how supplemental D₃ affects 25-OH-D₃ in the egg yolk	• Dietary vitamin D₃ concentrations: 26.6, 62.4, and 216.0 µg/kg	When D₃ content in feed was increased from 62.4 to 216 µg/kg, there was a 7-fold increase in egg yolk D₃ and 1.5-fold increase in 25-OH-D₃	(163)
Lohmann White	Examined how quickly and effectively, high concentrations of vitamin D₃ supplementation can transfer from feed to the egg yolk	• Basal dietary vitamin D₃ concentrations: 43 and 107 µg/kg• Experimental dietary vitamin D₃ concentrations: 280 and 300 µg/kg	Vitamin D content in egg yolk achieved a peak (30 µg D₃/100 g yolk weight) around 8–13 d from the start of the experimental high D₃ diets; feeding 1708.7 µg D₃/kg diet did not affect eggshell strength or harm the hens	(166)
Lohmann LSL White	Assessed dietary effects of vitamin D₂ and D₃ supplementation during entire egg-laying period	• Dietary D₃ concentrations: 62.5, 150.0, 375.0 µg/kg• Diets with D₂ contained 62.5 µg D₃ + 150.0 or 375.0 µg D₂	Dietary D₃ was more effective with increasing vitamin D content in the egg yolk compared to D₂; no negative effect of dietary supplementation of D₂ or D₃ on body weight or tibia strength	(167)
Hy-Line W-36	Determined the dietary effects of various concentrations of vitamin D₃ supplementation on laying hen production performance, bone health, and egg quality	• Dietary D₃ concentrations: 42.0, 208.7, 458.7, 875.35, and 1708.7 µg/kg	No dietary effect of D₃ supplementation on keel bone damage; increasing dietary vitamin D₃ supplementation concentrations led to increased vitamin D₃ content in the egg yolk	(168)
Dietary vitamin D supplementation effects on egg production
Hy-Line W-36	Determined if dietary supplementation of vitamin D₃, 1,25-(OH)₂-D₃, and 1α-OH-D₃ improved eggshell quality, egg production, and tibia strength	• Dietary 1α-OH-D₃ and 1,25-(OH)₂-D₃ concentrations for Exp. 1: 0, 0.75, 1.5, 3.0, 4.5 µg/kg• Dietary vitamin D₃ concentrations: 0, 12.5, 25.0, 37.5 µg/kg	1α-OH-D₃ and 1,25-(OH)₂-D₃ did not affect eggshell quality or egg production; increased dietary D₃ concentrations led to quadratically increased serum calcium at oviposition	(152)
Lohmann White	Examined increased dosage of dietary vitamin D₂, D₃, and 25-OH-D₃ on bone mineralization and egg production	• Basal diet contains 75.0 µg D₃/kg of diet• Supplemented vitamin D₂, D₃, and 25-OH-D₃ concentrations added to basal diet: 75.0 and 225.0 µg/kg	No soft tissue calcification was observed in hens fed diets with supplemental vitamin D concentrations; supplement doses did not affect egg quality, egg production, or bone health	(153)
Dietary vitamin supplementation effects on egg yolk content
Hy-Line W-36	Examine dietary effects of different sources of fatty acids and 2 concentrations of vitamin E on lipid profile in eggs	• Vitamin E concentrations: 10.9 and 90.9 mg/kg• Dietary D₃ concentration was 62.5 µg/kg	Fatty acid source influenced yolk lipid profile; interaction between fatty acid source and 90.9 mg of vitamin E/kg of diet, led to increased vitamin E content in egg	(158) ¹
Rhode Island Red	Evaluate dietary vitamin A supplementation on maternal hen on accumulation of vitamins A, E, C, and carotenoids in embryonic liver	• Dietary vitamin A supplementation concentrations: 0, 3, 30, and 120 µg retinol equivalent/g of diet	Egg yolk vitamin A content was increased as dietary vitamin A supplementation increased; however, vitamin E and carotenoid concentrations were reduced as a trade-off	(159) ²
Hy-Line Brown	Determine if dietary vitamin E supplementation in laying hen diets can fortify eggs in dose-dependent response	• Diets contained 40 mg of vitamin E and 0, 50,100, and 200 mg were added supplement concentrations• Dietary D₃ concentration was 75.0 µg/kg	Vitamin E in the egg yolk increased linearly as vitamin E in diet increased	(160) ³
Dietary calcium effects on egg production
Hy-Line W-36and Dekalb XL	Determine if increased dietary macronutrient concentrations, lacking calcium, leads to increased liver fat and affect egg size and production	• Dietary calcium concentrations ranged from 1.0 to 4.1%; there were multiple experiments with different concentrations within that range• Dietary D₃ concentration was 55.0 µg/kg	Lower calcium concentrations led to increased feed intake, body weight, liver weight, and fat pad; although, there was no effect on egg size or production	(154)
Hy-Line W-36	Does calcium and NaHCO₃ supplementation in diets with continuous feed access with 24-h light, lead to improved eggshell quality?	• NaHCO₃ supplementation: 0 or 0.5%; dietary calcium source: ground limestone or 1/3 ground limestone with 2/3 oyster shell• Dietary D₃ concentration was 41.3 µg/kg	Feeding supplementary NaHCO₃ increased egg elasticity and 24-h photoperiod improved eggshell quality	(155)

Vitamin E form was not stated; therefore, we assumed the authors used DL-α-tocopherol.

Article stated the hens were fed a proprietary breeders' wheat-barley-based diet so vitamin D content is not stated; vitamin A form used in the article was retinol-acetate.

Vitamin E form used for dietary supplementation in the study was DL-α-tocopherol.

1α-OH-D₃, 1-α-hydroxycholecalciferol; 1,25-(OH)₂-D₃, 1,25-dihydroxycholecalciferol; 25-OH-D₃, 25-hydroxycholecalciferol; NaHCO₃, sodium bicarbonate.

Vitamin D toxicity is rare but can occur due to an excessive intake of vitamin D from supplements (1). Holick (1) noted how humans taking daily vitamin D doses >1250 µg/d (50,000 IU/d) increase their serum 25-OH-D₃ concentration to 150 ng/mL which is associated with hypercalcemia and hyperphosphatemia. Laying hens fed 375 µg D₃/kg of feed (15,000 IU D₃/kg of feed) for 48 wk were observed to not have any histopathological issues with their liver, kidney, heart, and brain (167). Plasma vitamin D₃ was not measured in those laying hens, but the vitamin D₃ content in the egg yolk of those hens was increased relative to dietary vitamin D₃. Broiler chicks are reported to have a high tolerance to excess dietary D₃ because chicks fed 1250 µg D₃/kg of feed (50,000 IU D₃/kg of feed) had similar body weight gain, feed intake, and tibia ash as chicks fed 2.5 µg D₃/kg of feed (180). Based on what Baker et al. (180) observed compared with what Morrissey et al. (181) observed with chicks, feeding high concentrations of D₃ is nowhere near as toxic as 25-OH-D₃. There was a clinical trial during winter in which men were given daily oral doses of 5000 IU D₃ for ∼20 wk which led to an increase in serum 25-OH-D₃ concentration to maintain vitamin D status (54) (Table 1). When taken into consideration with what was observed with rats and chickens, excessive vitamin D₃ intake may not be as toxic as suspected, especially with regulatory feedback mechanisms.

Increasing the intake of 25-OH-D₃ may be more effective in eliciting vitamin D pathways for increasing Ca absorption, but there are risks associated with toxicity. Chicks fed diets containing 100 mg of 25-OH-D₃/kg of feed led to emaciation and deaths as a result of vitamin D intoxication (181). In young chicks, toxicity caused mineralization and lesions in kidneys, and fragile bones (181). In rats, excessive concentrations of dietary 25-OH-D₃ led to a linear decrease in body weight and rats given 4600 nmol/d of 25-OH-D₃ had grayish-white kidney coloration as a sign of calcification (182). Laying hens fed 825 µg 25-OH-D₃/kg of feed (10×) exhibited toxic effects such as a decrease in body weight, reduction in feed efficiency, decreased eggshell thickness, egg production, and egg quality parameters such as egg and albumen weights (183). Broiler chicks fed diets with 25-OH-D₃ containing 10x concentration (690 µg/kg) higher than the basal diet (69 µg/kg) exhibited renal calcification and their serum 25-OH-D₃ concentration was 242 ng/mL (184), but renal calcification may be dependent on dietary Ca (181). It is important to note that in Yarger et al.'s (184) study, chicks fed the diet with the lowest 25-OH-D₃ level (69 µg/kg) had a 25-OH-D₃ serum concentration of 37 ng/mL, highlighting how much 25-OH-D₃ can accumulate in serum. In a clinical study with adult men and women given single oral doses of 25-OH-D₃ (5 or 10 µg/kg), serum 25-OH-D₃ increased over a course of 4 h and then dropped to near baseline after a week (185). 25-OH-D₂ may be a safer form of vitamin D supplementation because it is not likely to be as potent and toxic compared to 25-OH-D₃ (186). Dietary supplemental 25-OH-D₃ dosages should be taken with extra care because of its potency and potential cause of pathologies.

VDR research in chickens has great potential to elucidate vitamin D metabolism

VDR is a transcription factor which 1,25-(OH)₂-D₃ binds to and exerts the activity of vitamin D through gene expression (187). When 1,25-(OH)₂-D₃ binds to VDR, a conformational change transforms VDR to interact with other factors in gene transcription (188). VDR is classified as a nuclear transcription factor which requires a specific ligand [1,25-(OH)₂-D₃] and heterodimerizes with the retinoid X receptor (RXR) (189). Found in many animals with some form of calcified skeleton (190) and lamprey (191), the evolutionary origins of VDR are still unclear. One of the primary functions of VDR is regulating Ca and phosphate homeostasis for bone mineralization as was characterized in VDR-null mice (192, 193). Genetic defects in VDR cause vitamin-D-dependent rickets type II (176) because Ca absorption for bone mineralization was heavily reduced as VDR is necessary for expressing proteins that facilitate Ca absorption. Bouillon et al. (190) reviewed how the VDR-null mouse model was significant in illustrating the role of VDR as a transcription factor involved with multiple physiological systems. In mammals, VDR mutations can lead to baldness because of a corepressor that binds to VDR (194, 195). VDR has also been found in the human brain along with 1α-hydroxylase, suggesting that vitamin D has autocrine/paracrine potential in the brain (131) (Table 1). Aging is also connected to reducing VDR expression in human muscle tissues (196).

An important element of VDR expression in most tissues in the body is its connection to immune function (197). Immune cells like macrophages express VDR (198) and when 1,25-(OH)₂-D₃ binds to VDR, then it causes signal transduction with immune activity (199). VDR is connected to anti-inflammatory elements and modulating anti-inflammatory cytokine activity while inhibiting proinflammatory cytokine production (200, 201). Research in mice has shown that lacking or having defective VDR led to increased inflammation (201, 202). Reduced or no signaling from VDR also highlights why vitamin D deficiency is correlated to increased inflammation (203). The connection of VDR to immune function will be a significant hotbed area of research in the future because of the global need to address vitamin D insufficiency.

There is a lack of research into the VDR in chickens that will be necessary for illustrating vitamin D mechanisms. However, the chicken genome has been sequenced (204, 205), so VDR has been annotated. There is some research that explored VDR as a biological candidate gene for improving production (growth rate for broilers, egg production and egg quality for laying hens) (206–208). VDR has also been shown to be a mediator for muscle tissue in broilers and in vitro (209). To our knowledge, there are currently no studies that have explored VDR and bone mineralization in the chicken model. Therefore, further characterizing VDR in chickens has significance for researchers and the poultry industry. Future research examining vitamin D using the chicken model should go a step further to examine how VDR expression is influenced, as such conditions can provide greater insights into vitamin D metabolism.

Hypothesis testing for vitamin D studies in chickens can increase their impact by considering VDR expression levels. VDR has been identified to be present in almost all tissues in mammalian models, but does the same principle apply to the avian model which has a distinctly different kidney structure (210) that is also very efficient? Birds evolved to mobilize Ca quickly from their bones for eggshell formation and this Ca may also be resorbed from the kidneys, which is also a site for VDR (211, 212). If chickens were fed exorbitant concentrations of 25-OH-D₃ and were at risk of renal calcification, then VDR expression with 1α-OHase should be greatly increased to explain that effect. However, the alternative hypothesis would be explained by a decrease in 24-OHase which can also explain why renal calcification would be possible because the chicken had a higher Ca absorption without feedback inhibition. By understanding how VDR is affected by experimental treatments in chickens, future researchers will be able to draw conclusions that can connect the biological effects of vitamin D. Such knowledge can be translated towards human nutrition to identify ways of addressing vitamin D insufficiency while reducing the risk of vitamin D toxicity.

Future research with vitamin D in chickens can help elucidate vitamin D deficiency-related issues to help address high-impact areas of human nutrition

The COVID-19 pandemic has led to a significant reduction in sunlight exposure for many people, as a result of lockdown and stay-home orders, inevitably increasing the risk of vitamin D deficiency (213, 214). Vitamin D deficiency is linked to a higher risk of COVID-19 infection because 1,25-(OH)₂-D₃ needs to bind to VDR for signal transduction pathways related to innate immunity (215). Vitamin D deficiency leads to increased inflammatory mediation from immune cells like macrophages, which exacerbates respiratory problems from severe acute respiratory coronavirus 2 (SARS-CoV-2), the virus responsible for the COVID-19 pandemic (215). Higher-risk populations to COVID-19 such as elderly people are more likely to have a lower serum 25-OH-D₃ concentration and be vitamin D deficient from reduced sunlight exposure (213, 216). Giving high supplemental doses of vitamin D₂ or D₃ to geriatric humans can address the vitamin D deficiency issue (217, 218). However, as of February 2021, there have yet to be any reported clinical studies on vitamin D supplementation reducing symptoms for those infected with COVID-19. Such clinical studies are likely underway and will be reported in the near future. Grant et al. (213) suggested that a combination of randomized controlled trials and large population studies are needed to examine if vitamin D supplementation can quickly increase 25-OH-D₃ concentration in humans to reduce the risk of influenza or COVID-19. We recommend that chickens would be a stellar model to work with because they would serve a dual purpose: 1) their added-value with production if vitamin D supplementation results in vitamin-D-enriched meat and egg products; and 2) provide data for translational research.

There is research interest in exploring vitamin D content in muscle tissue with different production animals. There was a study that involved pigs and showed how increased dietary vitamin D₃ and 25-OH-D₃ in feed increased vitamin D₃ and 25-OH-D₃ content in adipose and white muscle tissue (219). A recent review covered how 25-OH-D accumulates in skeletal muscle cells to be utilized during winter months (220). Also, a recent study reported how Irish beef contained vitamin D₂ and 25-OH-D₂ and other Irish meats contained little or immeasurable concentrations of the 2 metabolites (221). The study had samples collected from each of the 4 seasons. Median total vitamin D activity was observed at higher concentrations from samples collected in the summer and autumn, which indicates how meat may be a possible food source of vitamin D.

Broiler chickens would be valuable for elucidating vitamin D storage mechanisms because they can be housed in controlled environments to prevent UVB exposure. Broilers could also be fed dietary 25-OH-D₃ during their growing phases and have their 25-OH-D₃ concentration measured in plasma and muscle tissue. Using fast- and slow-growing broiler strains could serve as an excellent model for addressing Mason et al.'s (220) conclusions of exploring endocrine mechanisms regulating 25-OH-D₃ uptake and release in muscles. A study using broilers demonstrated that replacing most dietary D₃ with 25-OH-D₃ can increase the number of mitotically active skeletal muscle satellite cells, highlighting that dietary 25-OH-D₃ is connected to skeletal muscle yield (222). Building from Hutton et al.'s (222) findings, if dietary vitamin D₃ supplementation can increase vitamin D₃ concentrations in broiler chicken muscles, then there is a possibility for the poultry industry to cultivate a "vitamin D broiler" that yields muscles that contain higher concentrations of vitamin D₃ for consumers. These vitamin-D-enriched broilers can be important, not only for their increased added-value production, but they can also help alleviate issues relating to vitamin D deficiency cases that arise from the COVID-19 pandemic to even post-COVID-19.

Eggs are a staple food source that can help address vitamin D deficiency when the hens are fed diets with high concentrations of vitamin D₃ (167). The possibility of vitamin-D-enriched eggs was discussed earlier in this review in the section "Effects of dietary vitamin D₃ with laying hens in production." Exploring consumer aspects of vitamin-D-enriched eggs will be important for trying to address vitamin D deficiency because if the vitamin-D-enriched eggs lose a lot of their content from cooking, then their value is reduced. Therefore, it will be necessary to quantify how different processing methods affect vitamin D content in egg yolks, especially in vitamin-D-enriched eggs. Jakobsen and Knuthsen (223) published an analytical article that reported boiled or fried eggs had vitamin D retention that ranged from 82 to 88% and prolonged heat treatment in an oven resulted in 39–45% retention. Their article highlights that vitamin D content in eggs is influenced by cooking methods (223). Determination of the vitamin D content in egg yolks after cooking has significant implications for people who depend on dietary sources for vitamin D intake.

Chickens can be used as translational research models for experimental approaches involving vitamin D deficiency, inflammation, and respiratory diseases. Mycoplasma gallisepticum is a bacterial species that causes respiratory infections in chickens and other birds (224) that can be used as an infectious agent for studies involving chickens. Similar to the spike proteins of SARS-CoV-2 (225), M. gallisepticum also uses adhesins to attach to host cells for cell invasion (226). Considering COVID-19 elicits a proinflammatory response in the lungs, which can be more severe in people with vitamin D deficiency; M. gallisepticum can likely cause a similar response in vitamin-D-deficient chickens. A starting approach can use in vitro methods to characterize how chicken-derived macrophages and M. gallisepticum interactions are influenced with or without vitamin D treatment during incubation. Building from the in vitro study findings can help develop hypotheses using broilers or laying hens that are fed vitamin-D-deficient diets. They could be subsequently infected with M. gallisepticum to examine if there is an increase in proinflammatory immune marker expression. Characterizing inflammatory elements caused by respiratory disease agents in vitamin-D-deficient chickens could potentially identify markers that can help us develop alternate countermeasures against COVID-19 or other respiratory diseases.

Conclusions

Addressing global vitamin D insufficiency cannot be solely dependent on fortification methods or increasing sunlight exposure. Chickens are a valuable food source that have the potential to increase consumer vitamin D intake through egg and meat products that can be enriched with vitamin D. Research studies involving dietary vitamin D intake in chickens can help researchers develop critical questions to address undiscovered ways we can improve vitamin D intake and/or metabolism. We recommend future research involving chickens and vitamin D should incorporate more molecular techniques. Exploring physiological dimensions with how the birds are affected by vitamin D can illustrate gaps in knowledge where researchers can improve chicken nutrition. By advancing chicken nutrition knowledge in vitamin D, researchers can compare such strategies to humans to target and develop preventative strategies to improve vitamin D status.

ACKNOWLEDGEMENTS

We would like to thank Gavin Conant, Peter Ferket, Andrew Hardwick, Matt Koci, Catherine Lopez, Shannon Madden, and Marilyn Mayer who gave feedback for the initial manuscript and revision drafts. We would also like to thank the 2 anonymous reviewers for their time and valuable comments.

The authors' responsibilities were as follows—MFW: drafted the initial manuscript; MFW and KAL: critically revised the manuscript for important intellectual content; and both authors: read and approved the final manuscript.

Notes

The authors reported no funding was received for this study.

Author disclosures: The authors report no conflicts of interest.

Abbreviations used: COVID-19, coronavirus disease 2019; DBP, vitamin D binding protein; PTH, parathyroid hormone; SARS-CoV-2, severe acute respiratory syndrome coronavirus 2; TD, tibial dyschondroplasia; vitamin D₂, ergocalciferol; vitamin D₃, cholecalciferol; VDR, vitamin D receptor; 1α-OH-D₃, 1-α-hydroxycholecalciferol; 1α-OHase, 1α-hydroxylase; 1,25-(OH)₂-D₃, 1,25-dihydroxycholecalciferol; 7-DHC, 7-dehydrocholesterol; 24,25-(OH)₂-D₃, 24,25-dihydroxycholecalciferol; 24-OHase, 24-hydroxylase; 25-OH-D₂, 25-hydroxyergocalciferol; 25-OH-D₃, 25-hydroxycholecalciferol; 25-OHase, 25-hydroxylase.

References

Holick

Vitamin D deficiency

N Engl J Med

2007

;

357

(

266

–

Cashman

Vitamin D: dietary requirements and food fortification as a means of helping achieve adequate vitamin D status

J Steroid Biochem Mol Biol

2015

;

148

–

Omdahl

DeLuca

Regulation of vitamin D metabolism and function

1973

;

(

327

–

DeLuca

Overview of general physiologic features and functions of vitamin D

Am J Clin Nutr

2004

;

(

1689S

–

96S

Jones

Strugnell

DeLuca

Current understanding of the molecular actions of vitamin D

Physiol Rev

1998

;

(

1193

–

231

Chambers

Anderson

Salem

Bügel

Fenech

Mason

Weber

West

Jr,

Wilde

Eggersdorfer

et al.

The decline in vitamin research funding: a missed opportunity?

Curr Dev Nutr

2017

;

(

e000430

Mottet

Tempio

Global poultry production: current state and future outlook and challenges

World's Poultry Science Journal

2017

;

(

245

–

van der Pol

Molenaar

Buitink

van Roovert-Reijrink

Maatjens

van den Brand

Kemp

Lighting schedule and dimming period in early life: consequences for broiler chicken leg bone development

Poult Sci

2015

;

(

2980

–

Apeldoorn

Schrama

Mashaly

Parmentier

Effect of melatonin and lighting schedule on energy metabolism in broiler chickens

Poult Sci

1999

;

(

223

–

10.

Bahr

The chicken as a model organism

Sourcebook of Models for Biomedical Research

Springer

2008

161

–

11.

Thibodeau

Fravalo

Yergeau

Arsenault

Lahaye

Letellier

Chicken caecal microbiome modifications induced by Campylobacter jejuni colonization and by a non-antibiotic feed additive

PLoS One

2015

;

(

e0131978

12.

Gao

Sun

Wang

Huang

Zhang

Feed-additive probiotics accelerate yet antibiotics delay intestinal microbiota maturation in broiler chicken

Microbiome

2017

;

(

13.

De Los Santos

Donoghue

Venkitanarayanan

Metcalf

Reyes-Herrera

Dirain

Aguiar

Blore

Donoghue

The natural feed additive caprylic acid decreases Campylobacter jejuni colonization in market-aged broiler chickens

Poult Sci

2009

;

(

–

14.

Chen

Jr,

Bosmann

Comparison of the hypercalcemic action of vitamins D₂ and D₃ in chicks and the effect on tetracycline fixation by bone

J Nutr

1965

;

(

148

–

15.

Rodrıguez-Burford

Barnes

Berry

Partridge

Grizzle

Immunohistochemical expression of molecular markers in an avian model: a potential model for preclinical evaluation of agents for ovarian cancer chemoprevention

Gynecol Oncol

2001

;

(

373

–

16.

Barua

Bitterman

Abramowicz

Dirks

Bahr

Hales

Bradaric

Edassery

Rotmensch

Luborsky

Histopathology of ovarian tumors in laying hens: a preclinical model of human ovarian cancer

Int J Gynecol Cancer

2009

;

(

531

–

17.

Horst

Napoli

Littledike

Discrimination in the metabolism of orally dosed ergocalciferol and cholecalciferol by the pig, rat and chick

Biochem J

1982

;

204

(

185

18.

Dyck

Factors influencing sexual maturation, puberty and reproductive efficiency in the gilt

Can J Anim Sci

1988

;

(

–

19.

Holick

Frommer

McNeill

Richtand

Henley

Potts

Photometabolism of 7-dehydrocholesterol to previtamin D₃ in skin

Biochem Biophys Res Commun

1977

;

(

107

–

20.

Holick

MacLaughlin

Clark

Holick

Potts

Anderson

Blank

Parrish

Elias

Photosynthesis of previtamin D3 in human skin and the physiologic consequences

Science

1980

;

210

(

4466

203

–

21.

Holick

Pang

Schreibman

Phylogenetic and evolutionary aspects of vitamin D from phytoplankton to humans

Vertebrate endocrinology: fundamentals and biomedical implications

1989

;

–

22.

Pasanen

A-L

Yli-Pietilä

Pasanen

Kalliokoski

Tarhanen

Ergosterol content in various fungal species and biocontaminated building materials

Appl Environ Microbiol

1999

;

(

138

–

23.

Horst

Reinhardt

Reddy

Vitamin D metabolism

Vitamin D

2005

;

–

24.

Bikle

Vitamin D metabolism, mechanism of action, and clinical applications

Chem Biol

2014

;

(

319

–

25.

Havinga

Vitamin D, example and challenge

Experientia

1973

;

1181

–

26.

Holick

Environmental factors that influence the cutaneous production of vitamin D

Am J Clin Nutr

1995

;

(

638S

–

45S

27.

Holick

McCollum Award Lecture, 1994: vitamin D–new horizons for the 21st century

Am J Clin Nutr

1994

;

619

–

28.

Webb

Decosta

Holick

Sunlight regulates the cutaneous production of vitamin D3 by causing its photodegradation

J Clin Endocrinol Metab

1989

;

(

882

–

29.

Wacker

Holick

Sunlight and vitamin D: a global perspective for health

Dermato-endocrinology

2013

;

(

–

108

30.

Mawer

Lumb

Stanbury

Long biological half-life of vitamin D₃ and its polar metabolites in human serum

Nature

1969

;

222

(

5192

482

–

31.

Avioli

Lee

McDonald

Lund

DeLuca

Metabolism of vitamin D₃-3 H in human subjects: distribution in blood, bile, feces, and urine

J Clin Invest

1967

;

(

983

–

32.

Stipanuk MH, Caudill

Biochemical, Physiological, and Molecular Aspects of Human Nutrition

. :

Elsevier health sciences

;

2018

33.

Burkhardt

UV vision: a bird's eye view of feathers

J Comp Physiol

1989

;

164

(

787

–

34.

Hou

Studies on the Glandula Uropygialis of Birds

McGill University Libraries

1928

35.

Elder

The oil gland of birds

The Wilson Bulletin

1954

;

(

–

36.

Sandilands

Savory

Powell

Preen gland function in layer fowls: factors affecting morphology and feather lipid levels

Comp Biochem Physiol A Mol Integr Physiol

2004

;

137

(

217

–

37.

Knowles

Hart

Halpin

The relation of the preen gland to rickets in the domestic fowl

Poult Sci

1935

;

(

–

38.

Rosenberg

The site and nature of provitamin D in birds

Arch Biochem Biophys

1953

;

(

–

39.

Schutkowski

Krämer

Kluge

Hirche

Krombholz

Theumer

Stangl

UVB exposure of farm animals: study on a food-based strategy to bridge the gap between current vitamin D intakes and dietary targets

PLoS One

2013

;

(

e69418

40.

Bhattacharyya

DeLuca

The regulation of rat liver calciferol-25-hydroxylase

J Biol Chem

1973

;

248

(

2969

–

41.

Axén

Bergman

Wikvall

Purification and characterization of a vitamin D₃ 25-hydroxylase from pig liver microsomes

Biochem J

1992

;

287

(

725

–

42.

Holmberg

Berlin

Ewerth

Björkhem

25-Hydroxylase activity in subcellular fractions from human liver. Evidence for different rates of mitochondrial hydroxylation of vitamin D₂ and D₃

Scand J Clin Lab Invest

1986

;

(

785

–

43.

Bhattacharyya

DeLuca

The regulation of calciferol-25-hydroxylase in the chick

Biochem Biophys Res Commun

1974

;

(

734

–

44.

Tucker

III G

Gagnon

Haussler

Vitamin D₃-25-hydroxylase: tissue occurrence and apparent lack of regulation

Arch Biochem Biophys

1973

;

155

(

–

45.

Zhu

DeLuca

Vitamin D 25-hydroxylase – four decades of searching, are we there yet?

Arch Biochem Biophys

2012

;

523

(

–

46.

White

Cooke

The multifunctional properties and characteristics of vitamin D-binding protein

Trends Endocrinol Metab

2000

;

(

320

–

47.

Dawson-Hughes

Heaney

Holick

Lips

Meunier

Vieth

Estimates of Optimal Vitamin D Status

Osteoporos Int

2005

;

(

713

–

48.

Hollis

Circulating 25-hydroxyvitamin D levels indicative of vitamin D sufficiency: implications for establishing a new effective dietary intake recommendation for vitamin D

J Nutr

2005

;

135

(

317

–

49.

Horst

Littledike

Riley

Napoli

Quantitation of vitamin D and its metabolites and their plasma concentrations in five species of animals

Anal Biochem

1981

;

116

(

189

–

203

50.

Theodoropoulos

Demers

Mirshahi

Gascon-Barré

1, 25-Dihydroxyvitamin D₃ downregulates the rat intestinal vitamin D₃-25-hydroxylase CYP27A

American Journal of Physiology-Endocrinology and Metabolism

2001

;

281

(

E315

–

E25

51.

Walsh

Evans

Bowles

Naylor

Jones

Schoenmakers

Jacques

Eastell

Free 25-hydroxyvitamin D is low in obesity, but there are no adverse associations with bone health

Am J Clin Nutr

2016

;

103

(

1465

–

52.

Jones

Assar

Harnpanich

Bouillon

Lambrechts

Prentice

Schoenmakers

25(OH)D₂ half-life is shorter than 25(OH)D₃ half-life and is influenced by DBP concentration and genotype

J Clin Endocrinol Metab

2014

;

(

3373

–

53.

Ala-Houhala

Koskinen

Parviainen

Visakorpi

25-Hydroxyvitamin D and vitamin D in human milk: effects of supplementation and season

Am J Clin Nutr

1988

;

(

1057

–

54.

Heaney

Davies

Chen

Holick

Barger-Lux

Human serum 25-hydroxycholecalciferol response to extended oral dosing with cholecalciferol

Am J Clin Nutr

2003

;

(

204

–

55.

Barger-Lux

Heaney

Dowell

Chen

Holick

Vitamin D and its major metabolites: serum levels after graded oral dosing in healthy men

Osteoporos Int

1998

;

(

222

–

56.

Vieth

Chan

P-CR

MacFarlane

Efficacy and safety of vitamin D3 intake exceeding the lowest observed adverse effect level

Am J Clin Nutr

2001

;

(

288

–

57.

Whyte

Haddad

Jr,

Walters

Stamp

Vitamin D bioavailability: serum 25-hydroxyvitamin D levels in man after oral, subcutaneous, intramuscular, and intravenous vitamin D administration

J Clin Endocrinol Metab

1979

;

(

906

–

58.

Mazahery

Von Hurst

Factors affecting 25-hydroxyvitamin D concentration in response to vitamin D supplementation

Nutrients

2015

;

(

5111

–

59.

Shanmugasundaram

Selvaraj

Vitamin D-1α-hydroxylase and vitamin D-24-hydroxylase mRNA studies in chickens

Poult Sci

2012

;

(

1819

–

60.

Tanaka

DeLuca

Measurement of mammalian 25-hydroxyvitamin D₃ 24R-and 1 alpha-hydroxylase

Proc Natl Acad Sci

1981

;

(

196

–

61.

Norman

Myrtle

Miogett

Nowicki

Williams

Popjaák

1, 25-dihydroxycholecalciferol: identification of the proposed active form of vitamin D₃ in the intestine

Science

1971

;

173

(

3991

–

62.

Zehnder

Bland

Williams

McNinch

Howie

Stewart

Hewison

Extrarenal expression of 25-hydroxyvitamin D₃-1α-hydroxylase

J Clin Endocrinol Metab

2001

;

(

888

–

63.

Adams

Gacad

Characterization of 1 alpha-hydroxylation of vitamin D3 sterols by cultured alveolar macrophages from patients with sarcoidosis

J Exp Med

1985

;

161

(

755

–

64.

Rasmussen

Wong

Bikle

Goodman

Hormonal control of the renal conversion of 25-hydroxycholecalciferol to 1,25-dihydroxycholecalciferol

J Clin Invest

1972

;

(

2502

–

65.

Tsai

Wong

Norman

Studies on calciferol metabolism IV. Subcellular localization of 1,25-dihydroxy-vitamin D₃ in intestinal mucosa and correlation with increased calcium transport

J Biol Chem

1972

;

247

(

5511

–

66.

Brandi

Egfjord

Olgaard

Pharmacokinetics of 1,25(OH)₂D₃ and 1α(OH)D₃ in normal and uraemic men

Nephrology Dialysis Transplantation

2002

;

(

829

–

67.

Seeman

Kumar

Hunder

Scott

Heath

Riggs

Production, degradation, and circulating levels of 1,25-dihydroxyvitamin D in health and in chronic glucocorticoid excess

J Clin Invest

1980

;

(

664

–

68.

Holick

Vitamin D status: measurement, interpretation, and clinical application

Ann Epidemiol

2009

;

(

–

69.

Booth

Tsai

Morris

Vitamin D status regulates 25-hydroxyvitamin D3-1 alpha-hydroxylase and its responsiveness to parathyroid hormone in the chick

J Clin Invest

1985

;

(

155

–

70.

Horiuchi

Suda

Takahashi

Shimazawa

Ogata

In vivo evidence for the intermediary role of 3′,5′-cyclic AMP in parathyroid hormone-induced stimulation of lα,25-dihydroxy vitamin D₃ synthesis in rats

Endocrinology

1977

;

101

(

969

–

71.

Boyle

Gray

DeLuca

Regulation by calcium of in vivo synthesis of 1,25-dihydroxycholecalciferol and 21,25-dihydroxycholecalciferol

Proc Natl Acad Sci

1971

;

(

2131

–

72.

Shimada

Hasegawa

Yamazaki

Muto

Hino

Takeuchi

Fujita

Nakahara

Fukumoto

Yamashita

FGF-23 is a potent regulator of vitamin D metabolism and phosphate homeostasis

J Bone Miner Res

2003

;

(

429

–

73.

Hughes

Brumbaugh

Haussler

Wergedal

Baylink

Regulation of serum 1alpha,25-dihydroxyvitamin D₃ by calcium and phosphate in the rat

Science

1975

;

190

(

4214

578

–

74.

Shinki

Jin

Nishimura

Nagai

Ohyama

Noshiro

Okuda

Suda

Parathyroid hormone inhibits 25-hydroxyvitamin D₃-24-hydroxylase mRNA expression stimulated by 1 alpha,25-dihydroxyvitamin D₃ in rat kidney but not in intestine

J Biol Chem

1992

;

267

(

13757

–

75.

Rost

Bikle

Kaplan

In vitro stimulation of 25-hydroxycholecalciferol lα-hydroxylation by parathyroid hormone in chick kidney slices: evidence for a role for adenosine 3',5'-monophosphate

Endocrinology

1981

;

108

(

1002

–

76.

Brenza

Kimmel-Jehan

Jehan

Shinki

Wakino

Anazawa

Suda

DeLuca

Parathyroid hormone activation of the 25-hydroxyvitamin D₃-1α-hydroxylase gene promoter

Proc Natl Acad Sci

1998

;

(

1387

–

77.

Holick

Kleiner-Bossaller

Schnoes

Kasten

Boyle

DeLuca

1,24,25-Trihydroxyvitamin D₃: a metabolite of vitamin D₃ effective on intestine

J Biol Chem

1973

;

248

(

6691

–

78.

Holick

Schnoes

DeLuca

Gray

Boyle

Suda

Isolation and identification of 24,25-dihydroxycholecalciferol, a metabolite of vitamin D₃ made in the kidney

Biochemistry

1972

;

(

4251

–

79.

St-Arnaud

Arabian

Travers

Barletta

Raval-Pandya

Chapin

Depovere

Mathieu

Christakos

Demay

Deficient mineralization of intramembranous bone in vitamin D-24-hydroxylase-ablated mice is due to elevated 1,25-dihydroxyvitamin D and not to the absence of 24,25-dihydroxyvitamin D

Endocrinology

2000

;

141

(

2658

–

80.

Tanaka

DeLuca

Stimulation of 24,25-dihydroxyvitamin D₃ production by 1,25-dihydroxyvitamin D₃

Science

1974

;

183

(

4130

1198

–

200

81.

Kawashima

Torikai

Kurokawa

Localization of 25-hydroxyvitamin D₃ 1 alpha-hydroxylase and 24-hydroxylase along the rat nephron

Proc Natl Acad Sci

1981

;

(

1199

–

203

82.

Schlingmann

Kaufmann

Weber

Irwin

Goos

John

Misselwitz

Klaus

Kuwertz-Bröking

Fehrenbach

Mutations in CYP24A1 and idiopathic infantile hypercalcemia

N Engl J Med

2011

;

365

(

410

–

83.

Bosworth

Levin

Robinson-Cohen

Hoofnagle

Ruzinski

Young

Schwartz

Himmelfarb

Kestenbaum

De Boer

The serum 24,25-dihydroxyvitamin D concentration, a marker of vitamin D catabolism, is reduced in chronic kidney disease

Kidney Int

2012

;

(

693

–

700

84.

St-Arnaud

Targeted inactivation of vitamin D hydroxylases in mice

Bone

1999

;

(

127

–

85.

Veldurthy

Wei

Campbell

Lupicki

Dhawan

Christakos

25-Hydroxyvitamin D₃ 24-hydroxylase: a key regulator of 1,25(OH)2D₃ catabolism and calcium homeostasis

Vitamins & Hormones

Elsevier

2016

137

–

86.

Russell

Kanis

Smith

Adams

Bartlett

Cundy

Cochran

Heynen

Warner

Physiological and pharmacological aspects of 24,25-dihydroxycholecalciferol in man

Homeostasis of Phosphate and Other Minerals

Springer

1978

487

–

503

87.

Kanis

Taylor

Douglas

Cundy

Russell

Effects of 24,25-dihydroxy-vitamin D₃ on its plasma level in man

Metab Bone Dis Relat Res

1981

;

(

155

–

88.

Barton

Hesse

Pechet

Rizzardo

Convenient synthesis of 1-alpha-hydroxy-vitamin D₃

J Am Chem Soc

1973

;

(

2748

–

89.

Haussler

Zerwekh

Hesse

Rizzardo

Pechet

Biological activity of 1α-hydroxycholecalciferol, a synthetic analog of the hormonal form of vitamin D₃

Proc Natl Acad Sci

1973

;

(

2248

–

90.

Chalmers

Davie

Hunter

Szaz

Pelc

Kodicek

1-Alpha-hydroxycholecalciferol as a substitute for the kidney hormone 1,25-dihydroxycholecalciferol in chronic renal failure

Lancet North Am Ed

1973

;

302

(

7831

696

–

91.

Brickman

Coburn

Friedman

Okamura

Massry

Norman

Comparison of effects of 1 alpha-hydroxy-vitamin D₃ and 1,25-dihydroxy-vitamin D₃ in man

J Clin Invest

1976

;

(

1540

–

92.

Inouye

Sakaki

Enzymatic studies on the key enzymes of vitamin D metabolism; 1α-hydroxylase (CYP27B1) and 24-hydroxylase (CYP24)

Biotechnology Annual Review

Elsevier

2001

179

–

93.

Jones

Prosser

Kaufmann

Cytochrome P450-mediated metabolism of vitamin D

J Lipid Res

2014

;

(

–

94.

Toffolon

Pechet

Isselbacher

Demonstration of the rapid action of pure crystalline 1 alpha-hydroxy vitamin D₃ and 1 alpha, 25-dihydroxy vitamin D₃ on intestinal calcium uptake

Proc Natl Acad Sci

1975

;

(

229

–

95.

Hollander

Muralidhara

Zimmerman

Vitamin D-3 intestinal absorption in vivo: influence of fatty acids, bile salts, and perfusate pH on absorption

Gut

1978

;

(

267

–

96.

Paris

Clemens

Nolan

Holick

Vitamin D absorption in healthy subjects and in patients with intestinal malabsorption syndromes

Am J Clin Nutr

1985

;

(

644

–

97.

Reboul

Goncalves

Comera

Bott

Nowicki

Landrier

J-F

Jourdheuil-Rahmani

Dufour

Collet

Borel

Vitamin D intestinal absorption is not a simple passive diffusion: evidences for involvement of cholesterol transporters

Mol Nutr Food Res

2011

;

(

691

–

702

98.

Dawson-Hughes

Harris

Lichtenstein

Dolnikowski

Palermo

Rasmussen

Dietary fat increases vitamin D-3 absorption

Journal of the Academy of Nutrition and Dietetics

2015

;

115

(

225

–

99.

Hollander

Truscott

Mechanism and site of small intestinal uptake of vitamin D₃ in pharmacological concentrations

Am J Clin Nutr

1976

;

(

970

–

100.

Bar

Sharvit

Noff

Edelstein

Hurwitz

Absorption and excretion of cholecalciferol and of 25-hydroxycholecalciferol and metabolites in birds

J Nutr

1980

;

110

(

1930

–

101.

Sitrin

Bengoa

Intestinal absorption of cholecalciferol and 25-hydroxycholecalciferol in chronic cholestatic liver disease

Am J Clin Nutr

1987

;

(

1011

–

102.

Sitrin

Pollack

Bolt

Rosenberg

Comparison of vitamin D and 25-hydroxyvitamin D absorption in the rat

Am J Physiol

1982

;

242

(

G326

–

G32

103.

Hollander

Vitamin K1 absorption by everted intestinal sacs of the rat

American Journal of Physiology-Legacy Content

1973

;

225

(

360

–

104.

Loran

Althausen

Transport of vitamin A in vitro across normal isolated rat intestine and intestine subjected to 'partial' resection

American Journal of Physiology-Legacy Content

1959

;

197

(

1333

–

105.

Hoy

Ramberg

Jr,

Horst

Evidence that discrimination against ergocalciferol by the chick is the result of enhanced metabolic clearance rates for its mono- and dihydroxylated metabolites

J Nutr

1988

;

118

(

633

–

106.

Haddad

Matsuoka

Hollis

Wortsman

Human plasma transport of vitamin D after its endogenous synthesis

J Clin Invest

1993

;

(

2552

–

107.

Speeckaert

Huang

Delanghe

Taes

Biological and clinical aspects of the vitamin D binding protein (Gc-globulin) and its polymorphism

Clin Chim Acta

2006

;

372

(

1-2

–

108.

Cooke

David

Serum vitamin D-binding protein is a third member of the albumin and alpha fetoprotein gene family

J Clin Invest

1985

;

(

2420

–

109.

Bouillon

Van Baelen

Tan

De Moor

The isolation and characterization of the 25-hydroxyvitamin D-binding protein from chick serum

J Biol Chem

1980

;

255

(

10925

–

110.

Cooke

Haddad

Vitamin D binding protein (Gc-globulin)

Endocr Rev

1989

;

(

294

–

307

111.

Haddad

Fraser

Lawson

Vitamin D plasma binding protein. Turnover and fate in the rabbit

J Clin Invest

1981

;

(

1550

–

112.

Powe

Evans

Wenger

Zonderman

Berg

Nalls

Tamez

Zhang

Bhan

Karumanchi

Vitamin D-binding protein and vitamin D status of black Americans and white Americans

N Engl J Med

2013

;

369

(

1991

–

2000

113.

Chen

Wiepjes

van Schoor

Heijboer

de Jongh

den Heijer

Lips

Changes of Vitamin D-Binding Protein, and Total, Bioavailable, and Free 25-Hydroxyvitamin D in Transgender People

J Clin Endocrinol Metab

2019

;

104

(

2728

–

114.

Sinotte

Diorio

Berube

Pollak

Brisson

Genetic polymorphisms of the vitamin D binding protein and plasma concentrations of 25-hydroxyvitamin D in premenopausal women

Am J Clin Nutr

2009

;

(

634

–

115.

Reddy

Tserng

Calcitroic acid, end product of renal metabolism of 1,25-dihydroxyvitamin D3 through the C-24 oxidation pathway

Biochemistry

1989

;

(

1763

–

116.

Esvelt

DeLuca

Calcitroic acid: biological activity and tissue distribution studies

Arch Biochem Biophys

1981

;

206

(

403

–

117.

Mawer

Backhouse

Holman

Lumb

Stanbury

The distribution and storage of vitamin D and its metabolites in human tissues

Clin Sci

1972

;

(

413

–

118.

Park

Shin

Kim

J-H

Han

Tissue distribution of cholecalciferol and 25-hydroxycholecalciferol in normal and obese mice fed different levels of vitamin D (P24-003-19)

Current Developments in Nutrition

2019

;

(

Supplement_1

);

1992

119.

Patterson

Dolnikowski

Dawson-Hughes

Morris

Holland

Booth

Associations of vitamin D and vitamin K and their metabolites across four regions of the human brain: the memory and aging project (MAP) (FS05-02-19)

Current Developments in Nutrition

2019

;

(

Supplement_1

);

1262

120.

Ponchon

DeLuca

The role of the liver in the metabolism of vitamin D

J Clin Invest

1969

;

(

1273

–

121.

Horsting

DeLuca

In vitro production of 25-hydroxycholecalciferol

Biochem Biophys Res Commun

1969

;

(

251

–

122.

Prentice

Vitamin D deficiency: a global perspective

Nutr Rev

2008

;

(

suppl_2

S153

–

S64

123.

Hossein-Nezhad

Holick

Vitamin D for health: a global perspective

Mayo Clinic Proceedings

Elsevier

2013

720

–

124.

Mithal

Wahl

Bonjour

J-P

Burckhardt

Dawson-Hughes

Eisman

Fuleihan

GE-H

Josse

Lips

Morales-Torres

Global vitamin D status and determinants of hypovitaminosis D

Osteoporos Int

2009

;

(

1807

–

125.

Plum

DeLuca

Vitamin D, disease and therapeutic opportunities

Nat Rev Drug Discov

2010

;

(

941

–

126.

Zerofsky

Jacoby

Pedersen

Stephensen

Daily cholecalciferol supplementation during pregnancy alters markers of regulatory immunity, inflammation, and clinical outcomes in a randomized controlled trial

J Nutr

2016

;

146

(

2388

–

127.

Harris

Pittas

Palermo

A randomized, placebo-controlled trial of vitamin D supplementation to improve glycaemia in overweight and obese African Americans

Diabetes Obes Metab

2012

;

(

789

–

128.

Piccolo

Hall

Stephensen

Gertz

Van Loan

Circulating 25-hydroxyvitamin D concentrations in overweight and obese adults are explained by sun exposure, skin reflectance, and body composition

Current Developments in Nutrition

2019

;

(

doi:10.1093/cdn/nzz065

129.

Havens

Stephensen

Van Loan

Schuster

Woodhouse

Flynn

Gordon

Pan

Rutledge

Harris

et al.

Vitamin D₃ supplementation increases spine bone mineral density in adolescents and young adults with human immunodeficiency virus infection being treated with tenofovir disoproxil fumarate: a randomized, placebo-controlled trial

Clin Infect Dis

2018

;

(

220

–

130.

Larsen

Mosekilde

Foldspang

Vitamin D and calcium supplementation prevents osteoporotic fractures in elderly community dwelling residents: a pragmatic population-based 3-year intervention study

J Bone Miner Res

2003

;

(

370

–

131.

Eyles

Smith

Kinobe

Hewison

McGrath

Distribution of the vitamin D receptor and 1α-hydroxylase in human brain

J Chem Neuroanat

2005

;

(

–

132.

Imrie

Neville

Snellgrove

DeLuca

Metabolism of vitamin D₂ and vitamin D₃ in the rachitic chick

Arch Biochem Biophys

1967

;

120

(

525

–

133.

Orth

Cook

Avian tibial dyschondroplasia: a morphological and biochemical review of the growth plate lesion and its causes

Vet Pathol

1994

;

(

403

–

134.

Leach

Jr,

Monsonego-Ornan

Tibial dyschondroplasia 40 years later

Poult Sci

2007

;

(

2053

–

135.

Edwards

Jr.

Efficacy of several vitamin D compounds in the prevention of tibial dyschondroplasia in broiler chickens

J Nutr

1990

;

120

(

1054

–

136.

Whitehead

McCormack

McTeir

Fleming

High vitamin D3 requirements in broilers for bone quality and prevention of tibial dyschondroplasia and interactions with dietary calcium, available phosphorus and vitamin A

Br Poultry Sc

2004

;

(

425

–

137.

Fritts

Waldroup

Effect of source and level of vitamin D on live performance and bone development in growing broilers

J Appl Poultry Res

2003

;

(

–

138.

Browning

Cowieson

Interactive effect of vitamin D and strontium on performance and bone composition in broiler chickens

Anim Feed Sci Tech

2015

;

205

107

–

139.

Qian

Kornegay

Denbow

Utilization of phytate phosphorus and calcium as influenced by microbial phytase, cholecalciferol, and the calcium: total phosphorus ratio in broiler diets

Poult Sci

1997

;

(

–

140.

Driver

Atencio

Pesti

Edwards

Jr,

Bakalli

The effect of maternal dietary vitamin D₃ supplementation on performance and tibial dyschondroplasia of broiler chicks

Poult Sci

2006

;

(

–

141.

Zhang

Liu

McDaniel

Roland

Responses of broiler lines selected for tibial dyschondroplasia incidence to supplementary 25-hydroxycholecalciferol

J Appl Poult Res

1997

;

(

410

–

142.

Edwards

Jr.

The effect of dietary cholecalciferol, 25-hydroxycholecalciferol and 1,25-dihydroxycholecalciferol on the development of tibial dyschondroplasia in broiler chickens in the absence and presence of disulfiram

J Nutr

1989

;

119

(

647

–

143.

Waldroup

Ammerman

Harms

The relationship of phosphorus, calcium, and vitamin D₃ in the diet of broiler-type chicks

Poult Sci

1963

;

(

982

–

144.

Edwards

Jr,

Elliot

Sooncharernying

Britton

Quantitative requirement for cholecalciferol in the absence of ultraviolet light

Poult Sci

1994

;

(

288

–

145.

Elliot

Edwards

Jr.

Effect of 1, 25-dihydroxycholecalciferol, cholecalciferol, and fluorescent lights on the development of tibial dyschondroplasia and rickets in broiler chickens

Poult Sci

1997

;

(

570

–

146.

Rennie

Whitehead

Effectiveness of dietary 25- and 1-hydroxycholecalciferol in combating tibial dyschondroplasia in broiler chickens

Br Poult Sci

1996

;

(

413

–

147.

Aburto

Edwards

Jr,

Britton

The influence of vitamin A on the utilization and amelioration of toxicity of cholecalciferol, 25-hydroxycholecalciferol, and 1,25 dihydroxycholecalciferol in young broiler chickens

Poult Sci

1998

;

(

585

–

148.

Han

Chen

Zhang

Wang

Yan

Yang

Cheng

Relative biological value of 1α-hydroxycholecalciferol to 25-hydroxycholecalciferol in broiler chicken diets

Poult Sci

2017

;

(

2330

–

149.

Edwards

Shirley

Escoe

Pesti

Quantitative evaluation of 1-alpha-hydroxycholecalciferol as a cholecalciferol substitute for broilers

Poult Sci

2002

;

(

664

–

150.

Warren

Toomer

Fernandez

Livingston

Efficacy of 1-α-hydroxycholecalciferol supplementation in young broiler feed suggests reducing calcium levels at grower phase

Front Vet Sci

2020

;

245

151.

Desmarchelier

Margier

Prévéraud

Nowicki

Rosilio

Borel

Reboul

Comparison of the micellar incorporation and the intestinal cell uptake of cholecalciferol, 25-hydroxycholecalciferol and 1-α-hydroxycholecalciferol

Nutrients

2017

;

(

1152

152.

Frost

Roland Sr

Untawale

Influence of vitamin D₃, 1α-hydroxyvitamin D₃, and 1,25-dihydroxyvitamin D₃ on eggshell quality, tibia strength, and various production parameters in commercial laying hens

Poult Sci

1990

;

(

2008

–

153.

Adhikari

White

House

Kim

Effects of additional dosage of vitamin D₃, vitamin D₂, and 25-hydroxyvitamin D₃ on calcium and phosphorus utilization, egg quality and bone mineralization in laying hens

Poult Sci

2020

;

(

364

–

154.

Roland

Farmer

Marple

Calcium and its relationship to excess feed consumption, body weight, egg size, fat deposition, shell quality, and fatty liver hemorrhagic syndrome

Poult Sci

1985

;

(

2341

–

155.

Makled

Charles

Eggshell quality as influenced by sodium bicarbonate, calcium source, and photoperiod

Poult Sci

1987

;

(

705

–

156.

Wojtusik

Johnson

Vitamin D regulates anti-Mullerian hormone expression in granulosa cells of the hen

Biol Reprod

2012

;

(

157.

Surai

Sparks

NHC

Designer eggs: from improvement of egg composition to functional food

Trends Food Sci Technol

2001

;

(

–

158.

Mazalli

Faria

DEd

Salvador

Ito

A comparison of the feeding value of different sources of fat for laying hens: 2. lipid, cholesterol, and vitamin E profiles of egg yolk

J Appl Poult Res

2004

;

(

280

–

159.

Surai

Ionov

Kuklenko

Kostjuk

Acpherson

Speake

Noble

Sparks

Effect of supplementing the hen's diet with vitamin A on the accumulation of vitamins A and E, ascorbic acid and carotenoids in the egg yolk and in the embryonic liver

Br Poult Sci

1998

;

(

257

–

160.

Meluzzi

Sirri

Manfreda

Tallarico

Franchini

Effects of dietary vitamin E on the quality of table eggs enriched with n-3 long-chain fatty acids

Poult Sci

2000

;

(

539

–

161.

Combs

Jr.

Differential effects of high dietary levels of vitamin A on the vitamin E-selenium nutrition of young and adult chickens

J Nutr

1976

;

106

(

967

–

162.

Pudelkiewicz

Webster

Matterson

Effects of high levels of dietary vitamin A acetate on tissue tocopherol and some related analytical observations

J Nutr

1964

;

(

113

–

163.

Mattila

Lehikoinen

Kiiskinen

Piironen

Cholecalciferol and 25-hydroxycholecalciferol content of chicken egg yolk as affected by the cholecalciferol content of feed

J Agric Food Chem

1999

;

(

4089

–

164.

Medicine Io. Dietary reference intakes for calcium and vitamin D

National Academies Press

2011

165.

Intakes IoMSCotSEoDR

Dietary reference intakes

Dietary Reference Intakes for Calcium, Phosphorus, Magnesium, Vitamin D, and Fluoride

National Academies Press (US)

1997

166.

Mattila

Rokka

Könkö

Valaja

Rossow

Ryhänen

E-L

Effect of cholecalciferol-enriched hen feed on egg quality

J Agric Food Chem

2003

;

(

283

–

167.

Mattila

Valaja

Rossow

Venäläinen

Tupasela

Effect of vitamin D₂- and D₃-enriched diets on egg vitamin D content, production, and bird condition during an entire production period

Poult Sci

2004

;

(

433

–

168.

Wen

Livingston

Persia

Effect of high concentrations of dietary vitamin D₃ on pullet and laying hen performance, skeleton health, eggshell quality, and yolk vitamin D₃ content when fed to W36 laying hens from day of hatch until 68 wk of age

Poult Sci

2019

;

(

6713

–

169.

Glerup

Mikkelsen

Poulsen

Hass

Overbeck

Andersen

Charles

Eriksen

Hypovitaminosis D myopathy without biochemical signs of osteomalacic bone involvement

Calcif Tissue Int

2000

;

(

419

–

170.

Baylink

Stauffer

Wergedal

Rich

Formation, mineralization, and resorption of bone in vitamin D-deficient rats

J Clin Invest

1970

;

(

1122

–

171.

Wagner

Greer

Prevention of rickets and vitamin D deficiency in infants, children, and adolescents

Pediatrics

2008

;

122

(

1142

–

172.

Zhen

Liu

Guan

Zhao

Tang

High prevalence of vitamin D deficiency among middle-aged and elderly individuals in northwestern China: its relationship to osteoporosis and lifestyle factors

Bone

2015

;

–

173.

Chapuy

Preziosi

Maamer

Arnaud

Galan

Hercberg

Meunier

Prevalence of vitamin D insufficiency in an adult normal population

Osteoporos Int

1997

;

(

439

–

174.

Hyppönen

Power

Hypovitaminosis D in British adults at age 45 y: nationwide cohort study of dietary and lifestyle predictors

Am J Clin Nutr

2007

;

(

860

–

175.

Guillemant

Maria

Allemandou

Pérès

Guillemant

Wintertime vitamin D deficiency in male adolescents: effect on parathyroid function and response to vitamin D₃ supplements

Osteoporos Int

2001

;

(

875

–

176.

Pirro

Amling

Delling

Baron

Bronson

Demay

Targeted ablation of the vitamin D receptor: an animal model of vitamin D-dependent rickets type II with alopecia

Proc Natl Acad Sci

1997

;

(

9831

–

177.

Sutton

ALM

Zhang

Ellison

MacDonald

The 1, 25(OH)2D3-regulated transcription factor mn1 stimulates vitamin D receptor-mediated transcription and inhibits osteoblastic cell proliferation

Mol Endocrinol

2005

;

(

2234

–

178.

Kallay

Pietschmann

Toyokuni

Bajna

Hahn

Mazzucco

Bieglmayer

Kato

Cross

Characterization of a vitamin D receptor knockout mouse as a model of colorectal hyperproliferation and DNA damage

Carcinogenesis

2001

;

(

1429

–

179.

Larriba

Ordóñez-Morán

Chicote

Martín-Fernández

Puig

Muñoz

Pálmer

Vitamin D receptor deficiency enhances Wnt/β-catenin signaling and tumor burden in colon cancer

PLoS One

2011

;

(

e23524

180.

Baker

Biehl

Emmert

Vitamin D₃ requirement of young chicks receiving diets varying in calcium and available phosphorus

Br Poult Sci

1998

;

(

413

–

181.

Morrissey

Cohn

Empson

Jr,

Greene

Taunton

Ziporin

Relative toxicity and metabolic effects of cholecalciferol and 25-hydroxycholecalciferol in chicks

J Nutr

1977

;

107

(

1027

–

182.

Shepard

Deluca

Plasma concentrations of vitamin D₃ and its metabolites in the rat as influenced by vitamin D₃ or 25-hydroxyvitamin D₃ intakes

Arch Biochem Biophys

1980

;

202

(

–

183.

Terry

Lanenga

McNaughton

Stark

Safety of 25-hydroxyvitamin D₃ as a source of vitamin D₃ in layer poultry feed

Vet Hum Toxicol

1999

;

(

312

–

184.

Yarger

Quarles

Hollis

Gray

Safety of 25-hydroxycholecalciferol as a source of cholecalciferol in poultry rations

Poult Sci

1995

;

(

1437

–

185.

Haddad

Jr,

Rojanasathit

Acute administration of 25-hydroxycholecalciferol in man

J Clin Endocrinol Metab

1976

;

(

284

–

186.

Suda

DeLuca

Tanaka

Biological activity of 25-hydroxyergocalciferol in rats

J Nutr

1970

;

100

(

1049

–

187.

Haussler

Bartik

Whitfield

Hsieh

J-C

Slater

Jurutka

Vitamin D receptor: molecular signaling and actions of nutritional ligands in disease prevention

Nutr Rev

2008

;

(

suppl_2

S98

–

S112

188.

Haussler

Jurutka

Mizwicki

Norman

Vitamin D receptor (VDR)-mediated actions of 1α,25(OH)₂ vitamin D₃: genomic and non-genomic mechanisms

Best Pract Res Clin Endocrinol Metab

2011

;

(

543

–

189.

Victor

Delsert

Andersen

Holloway

Devary

Näär

Kim

Boutin

J-M

Glass

Rosenfeld

RXRβ: a coregulator that enhances binding of retinoic acid, thyroid hormone, and vitamin D receptors to their cognate response elements

Cell

1991

;

(

1251

–

190.

Bouillon

Carmeliet

Verlinden

van Etten

Verstuyf

Luderer

Lieben

Mathieu

Demay

Vitamin D and human health: lessons from vitamin D receptor null mice

Endocr Rev

2008

;

(

726

–

191.

Whitfield

Dang

Schluter

Bernstein

Bunag

Manzon

Hsieh

Encinas Dominguez

Youson

Haussler

Cloning of a functional vitamin D receptor from the lamprey (Petromyzon marinus), an ancient vertebrate lacking a calcified skeleton and teeth

Endocrinology

2003

;

144

(

2704

–

192.

Yoshizawa

Handa

Uematsu

Takeda

Sekine

Yoshihara

Kawakami

Arioka

Sato

Uchiyama

Mice lacking the vitamin D receptor exhibit impaired bone formation, uterine hypoplasia and growth retardation after weaning

Nat Genet

1997

;

(

391

–

193.

Van Cromphaut

Dewerchin

Hoenderop

Stockmans

Van Herck

Kato

Bindels

Collen

Carmeliet

Bouillon

Duodenal calcium absorption in vitamin D receptor-knockout mice: functional and molecular aspects

Proc Natl Acad Sci

2001

;

(

13324

–

194.

Xie

Chang

Oda

Bikle

Hairless suppresses vitamin D receptor transactivation in human keratinocytes

Endocrinology

2006

;

147

(

314

–

195.

Hsieh

J-C

Sisk

Jurutka

Haussler

Slater

Haussler

Thompson

Physical and functional interaction between the vitamin D receptor and hairless corepressor, two proteins required for hair cycling

J Biol Chem

2003

;

278

(

38665

–

196.

Bischoff-Ferrari

Borchers

Gudat

Dürmüller

Stähelin

Dick

Vitamin D receptor expression in human muscle tissue decreases with age

J Bone Miner Res

2004

;

(

265

–

197.

Baeke

Takiishi

Korf

Gysemans

Mathieu

Vitamin D: modulator of the immune system

Curr Opin Pharmacol

2010

;

(

482

–

198.

Kreutz

Andreesen

Krause

Szabo

Ritz

Reichel

1,25-dihydroxyvitamin D₃ production and vitamin D₃ receptor expression are developmentally regulated during differentiation of human monocytes into macrophages

Blood

1993

;

(

1300

–

199.

Bikle

Nonclassic actions of vitamin D

J Cli Endocrino Metab

2009

;

(

–

200.

Wang

Yang

Zhang

Zhao

Vitamin D/VDR signaling inhibits LPS-induced IFNγ and IL-1β in oral epithelia by regulating hypoxia-inducible factor-1α signaling pathway

Cell Commun Signal

2019

;

(

201.

Froicu

Zhu

Cantorna

Vitamin D receptor is required to control gastrointestinal immunity in IL-10 knockout mice

Immunology

2006

;

117

(

310

–

202.

Kim

J-H

Yamaori

Tanabe

Johnson

Krausz

Kato

Gonzalez

Implication of intestinal VDR deficiency in inflammatory bowel disease

Biochim Biophys Acta

2013

;

1830

(

2118

–

203.

Agrawal

Gupta

Agrawal

Vitamin D deficiency decreases the expression of VDR and prohibitin in the lungs of mice with allergic airway inflammation

Exp Mol Pathol

2012

;

(

–

204.

Hillier

Miller

Birney

Warren

Hardison

Ponting

Bork

Burt

Groenen

International Chicken Genome Sequencing Consortium

et al.

Sequence and comparative analysis of the chicken genome provide unique perspectives on vertebrate evolution

Nature

2004

;

432

695

–

716

205.

Warren

Hillier

Tomlinson

Minx

Kremitzki

Graves

Markovic

Bouk

Pruitt

Thibaud-Nissen

A new chicken genome assembly provides insight into avian genome structure

2017

;

(

109

–

206.

Bennett

Hester

Spurlock

Polymorphisms in vitamin D receptor, osteopontin, insulin-like growth factor 1 and insulin, and their associations with bone, egg and growth traits in a layer-broiler cross in chickens

Anim Genet

2006

;

(

283

–

207.

Han

Zhang

Yang

Guo

Shi

Yan

Age, phosphorus, and 25-hydroxycholecalciferol regulate mRNA expression of vitamin D receptor and sodium-phosphate cotransporter in the small intestine of broiler chickens

Poult Sci

2018

;

(

1199

–

208

208.

Ieda

Saito

Ono

Shimada

Effects of presence of an egg and calcium deposition in the shell gland on levels of messenger ribonucleic acid of CaBP-D_28K and of vitamin D₃ receptor in the shell gland of the laying hen

Gen Comp Endocrinol

1995

;

(

145

–

209.

Vignale

Greene

Caldas

England

Boonsinchai

Sodsee

Pollock

Dridi

Coon

25-hydroxycholecalciferol enhances male broiler breast meat yield through the mTOR pathway

J Nutr

2015

;

145

(

855

–

210.

Goldstein

Braun

Structure and concentrating ability in the avian kidney

American Journal of Physiology-Regulatory, Integrative and Comparative Physiology

1989

;

256

(

R501

–

211.

Sunn

Cock

T-A

Crofts

Eisman

Gardiner

Novel N-terminal variant of human VDR

Mol Endocrinol

2001

;

(

1599

–

609

212.

Zheng

Altered gene expression profile in the kidney of vitamin D receptor knockout mice

J Cell Biochem

2003

;

(

709

–

213.

Grant

Lahore

McDonnell

Baggerly

French

Aliano

Bhattoa

Evidence that vitamin D supplementation could reduce risk of influenza and COVID-19 infections and deaths

Nutrients

2020

;

(

988

214.

Yousfi

Bragazzi

Briki

Zmijewski

Chamari

The COVID-19 pandemic: how to maintain a healthy immune system during the lockdown – a multidisciplinary approach with special focus on athletes

Biol Sport

2020

;

(

211

–

215.

Bilezikian

Bikle

Hewison

Lazaretti-Castro

Formenti

Gupta

Madhavan

Nair

Babalyan

Hutchings

Mechanisms in endocrinology: vitamin D and COVID-19

Eur J Endocrinol

2020

;

183

(

R13

–

R47

216.

D'Avolio

Avataneo

Manca

Cusato

De Nicolò

Lucchini

Keller

Cantù

25-Hydroxyvitamin D concentrations are lower in patients with positive PCR for SARS-CoV-2

Nutrients

2020

;

(

1359

217.

Grant

Avenell

Campbell

McDonald

MacLennan

McPherson

Anderson

Cooper

Francis

Donaldson

et al.

Oral vitamin D₃ and calcium for secondary prevention of low-trauma fractures in elderly people (Randomised Evaluation of Calcium Or vitamin D, RECORD): a randomised placebo-controlled trial

Lancet

2005

;

365

(

9471

1621

–

218.

Romagnoli

Mascia

Cipriani

Fassino

Mazzei

D'Erasmo

Carnevale

Scillitani

Minisola

Short and long-term variations in serum calciotropic hormones after a single very large dose of ergocalciferol (vitamin D₂) or cholecalciferol (vitamin D₃) in the elderly

J Clin Endocrinol Metab

2008

;

(

3015

–

219.

Burild

Lauridsen

Faqir

Sommer

Jakobsen

Vitamin D₃ and 25-hydroxyvitamin D₃ in pork and their relationship to vitamin D status in pigs

J Nutr Sci

2016

;

220.

Mason

Rybchyn

Abboud

Brennan-Speranza

Fraser

The role of skeletal muscle in maintaining vitamin D status in winter

Current Developments in Nutrition

2019

;

(

221.

Cashman

O'Sullivan

Galvin

Ryan

Contribution of vitamin D₂ and D₃ and their respective 25-hydroxy metabolites to the total vitamin D content of beef and lamb

Current Developments in Nutrition

2020

doi:10.1093/cdn/nzaa112

222.

Hutton

Vaughn

Litta

Turner

Starkey

Effect of vitamin D status improvement with 25-hydroxycholecalciferol on skeletal muscle growth characteristics and satellite cell activity in broiler chickens1,2

J Anim Sci

2014

;

(

3291

–

223.

Jakobsen

Knuthsen

Stability of vitamin D in foodstuffs during cooking

Food Chem

2014

;

148

170

–

224.

Ley

Mycoplasma gallisepticum infection in poultry

Merck Veterinary Manual Merck Sharp & Dohme Corp

2016

225.

Hoffmann

Kleine-Weber

Pöhlmann

A multibasic cleavage site in the spike protein of SARS-CoV-2 is essential for infection of human lung cells

Mol Cell

2020

;

(

779

–

226.

Fürnkranz

Siebert-Gulle

Rosengarten

Szostak

Factors influencing the cell adhesion and invasion capacity of Mycoplasma gallisepticum

Acta Vet Scand

2013

;

(

Email alerts

Citing articles via

Latest
Most Read
Most Cited

In vivo Effects of Coffee Containing Javamide-I/-II on Body Weight, LDL, HDL, Total Cholesterol, Triglycerides, Leptin, Adiponectin, C-reactive Protein, sE-selectin, TNF-alpha, and MCP-1

How to Increase Vitamen D-3 in a Chickens Diet

Source: https://academic.oup.com/cdn/article/5/5/nzab018/6149455

How to Increase Vitamen D-3 in a Chickens Diet

Implications of Vitamin D Research in Chickens can Advance Human Nutrition and Perspectives for the Future

Abstract

Introduction

Search strategy and methodology

Vitamin D metabolites and mechanisms

25-Hydroxylation

1-Hydroxylation

24-Hydroxylation

1-α-Hydroxycholecalciferol

Vitamin D absorption, transportation, excretion, and tissue distribution

Addressing vitamin D insufficiency in humans by understanding vitamin D metabolism in chickens

Value of dietary vitamin D₃ with broiler chicken production

Effects of dietary vitamin D₃ with laying hens in production

Vitamin D deficiency and toxicity in humans and chickens

VDR research in chickens has great potential to elucidate vitamin D metabolism

Future research with vitamin D in chickens can help elucidate vitamin D deficiency-related issues to help address high-impact areas of human nutrition

Conclusions

ACKNOWLEDGEMENTS

Notes

References

Email alerts

More on this topic

Related articles in PubMed

Citing articles via

Latest

Most Read

Most Cited

0 Response to "How to Increase Vitamen D-3 in a Chickens Diet"

Post a Comment

Iklan Atas Artikel

Iklan Tengah Artikel 1

Iklan Tengah Artikel 2

Iklan Bawah Artikel

How to Increase Vitamen D-3 in a Chickens Diet

Implications of Vitamin D Research in Chickens can Advance Human Nutrition and Perspectives for the Future

Abstract

Introduction

Search strategy and methodology

Vitamin D metabolites and mechanisms

25-Hydroxylation

1-Hydroxylation

24-Hydroxylation

1-α-Hydroxycholecalciferol

Vitamin D absorption, transportation, excretion, and tissue distribution

Addressing vitamin D insufficiency in humans by understanding vitamin D metabolism in chickens

Value of dietary vitamin D3 with broiler chicken production

Effects of dietary vitamin D3 with laying hens in production

Vitamin D deficiency and toxicity in humans and chickens

VDR research in chickens has great potential to elucidate vitamin D metabolism

Future research with vitamin D in chickens can help elucidate vitamin D deficiency-related issues to help address high-impact areas of human nutrition

Conclusions

ACKNOWLEDGEMENTS

Notes

References

Email alerts

More on this topic

Related articles in PubMed

Citing articles via

Latest

Most Read

Most Cited

0 Response to "How to Increase Vitamen D-3 in a Chickens Diet"

Post a Comment

Iklan Atas Artikel

Iklan Tengah Artikel 1

Iklan Tengah Artikel 2

Iklan Bawah Artikel

Value of dietary vitamin D₃ with broiler chicken production

Effects of dietary vitamin D₃ with laying hens in production